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Abstract
Many important scientiﬁc questions can not be studied properly using a single measurement
as a response. For example, many phenotypes of interest in recent clinical research may be
di cult to characterize due to their inherent complexity. It may be di cult to determine the
presence or absence of disease based on a single measurement, or even a few measurements,
or the phenotype may only be deﬁned based on a series of symptoms. Similarly, a set of
related phenotypes or measurements may be studied together in order to detect a shared
etiology. In this work, we propose methods for studying complex phenotypes of these types,
where the phenotype may be characterized either longitudinally or by a diverse set of contin-
uous, discrete, or not fully observed components. In chapter 1, we seek to identify predictors
that are related to multiple components of diverse outcomes. We take up speciﬁcally the
question of identifying a multiple regulator, where we seek a genetic marker that is associated
with multiple biomarkers for autoimmune disease. To do this, we propose sparse multiple
regulation testing (SMRT) both to estimate the relationship between a set of predictors and
diverse outcomes and to provide a testing framework in which to identify which predictors are
associated with multiple elements of the outcomes, while controlling error rates. In chapter
2, we seek to identify risk proﬁles or risk scores for diverse outcomes, where a risk proﬁle is
al i n e a rc o m b i n a t i o no fp r e d i c t o r s .T h er i s kp r o ﬁ l e sw i l lb ec h o s e nt ob eh i g h l yc o r r e l a t e dt o
latent traits underlying the outcomes. To do this, we propose semiparametric canonical cor-
relation analysis (sCCA), an updated version of the classical canonical correlation analysis.
In chapter 3, the scientiﬁc question of interest pertains directly to the progression of disease
over time. We provide a testing framework in which to detect the association between a
set of genetic markers and the progression of disease in the context of a GWAS. To test for
this association while allowing for highly nonlinear longitudinal progression of disease, we
propose functional principal variance component (FPVC) testing.
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semiparametric models
Denis Agniel, Katherine P. Liao, and Tianxi Cai
Department of Biostatistics
Harvard School of Public Health
11.1 Introduction
In recent years, considerable interest has been focused on studying multiple phenotypes si-
multaneously in both epidemiological and genomic studies. There are several reasons for
such studies to be important. First, a complex disorder is usually associated with multiple
correlated phenotypes. Hence, even when the focus of the study is on a single disease, mul-
tiple phenotypes might be needed to fully capture the complexity and multidimensionality
of the disorder. Second, multiple related disorders might share the same etiology and a joint
assessment will enable researchers to identify factors associated with risk of multiple diseases.
In genetics, researchers might hypothesize that a group of related diseases share a common
genetic basis. As an example, recent studies have identiﬁed common genes associated with
a higher risk of what were previously considered distinct autoimmune diseases (Zhernakova
et al., 2009; Xavier and Rioux, 2008). Similar shared genetic bases have also been sug-
gested for various types of cancers and related psychiatric disorders (Solovie↵ et al., 2013).
Identiﬁcation of predictors of multiple outcomes, also commonly known as multiple traits
in the genetics literature, can improve understanding of disease etiology, genetic regulatory
pathways, and treatment. Further complicating matters, the measurements of the outcomes
may be diverse: they may be binary (e.g., presence of disease), continuous (disease activity
score), ordinal (severity of disease), not completely observable (perhaps due to a limit of
quantiﬁcation), or any combination thereof.
To address these questions statistically, we seek to assess the association between a vec-
tor of predictors x =( x1,...,x p)
T and a vector of outcomes y =( y(1),...,y(M))
T by estimating
and testing all relevant e↵ects. For each predictor xj we desire an estimation and testing
procedure that will identify its associated subset of y.I np a r t i c u l a r ,r e s e a r c h e r so f t e nw a n t
to identify predictors that are important for multiple or all outcomes. We will call xj a
“multiple regulator” if it is associated with more than one outcome, a terminology which we
adapt from Peng et al. (2010). An example of what we call multiple regulation is known as
pleiotropy in the genetics literature. Our goal of identifying multiple regulation is not to be
confused with identifying predictors that are associated with any outcomes. Association with
any outcomes has been an active area of research in recent years, with two examples being
2global association tests and group-sparse regularization. Association tests provide a test for
the relationship between xj and the entire set y (Lange et al., 2003; Jiang and Zeng, 1995)
and have been shown in some situations to have higher power than marginal tests to detect
associations when xj relates to multiple outcomes (Zhu and Zhang, 2009). Group-sparse
methods, largely based on the group lasso (Yuan and Lin, 2006), select predictors that are
relevant for any outcome (Turlach et al., 2005; Obozinski et al., 2011).
Here, we are particularly interested in identifying predictors that are relevant for multi-
ple outcomes and inferring which subset of y each of the xj’s are associated with. There is a
paucity of literature that addresses these speciﬁc questions. Under linear regression models,
the remMap procedure (Peng et al., 2010) addresses such a question via variable selection
by jointly penalizing both the L1 and L2 group norms of a squared loss. Under generalized
linear models, one could potentially modify the hierarchical lasso (Zhou and Zhu, 2010) pro-
cedure, originally proposed to handle grouped predictors with a single outcome, to address
the multiple regulator problem. However, these methods are not applicable when y consists
of a mixture of outcomes with di↵erent scales.
Furthermore, regardless of estimation technique, a multiple testing procedure is required
to control error rates when identifying multiple regulation, which operates on the (poten-
tially large) set of hypotheses {H
(m)
j : xj unassociated with y(m)}j=1,...,p;m=1,...,M. None of
the existing methods for multiple regulation tackles this issue. In general, multiple testing
based on regularized estimation is challenging for two reasons. First, while many of the reg-
ularization procedures such as Zhou and Zhu (2010) established asymptotic oracle properties
for their estimators — non-informative predictors can be detected with no uncertainty and
their detection induces no additional variation in the estimation of the informative predic-
tors (Fan and Li, 2001; Zou, 2006) — in ﬁnite samples those properties may be far from
holding. Consequently, basing testing procedures on such asymptotic results may lead to
inﬂated type I error in ﬁnite samples. Second, the estimators and hence their corresponding
test statistics could be highly correlated from the regression ﬁtting. Standard methods, in-
cluding the Bonferroni procedure to control the familywise error rate (FWER) and various
false discovery rate (FDR) controlling procedures (Benjamini and Hochberg, 1995), ignore
3Figure 1.1: Sampling distributions of null and non-null e↵ects, with and without regulariza-
tion. Tails of the distributions are truncated for ease of presentation.
information about the joint distribution of the test statistics outside of the ordered p-values
and either require positive dependency or tend to be conservative.
We propose a two-stage technique to both estimate the e↵ects of x on y and identify
multiple regulation while controlling error rates. In the ﬁrst stage, we use regularization to
induce sparsity in the estimated e↵ects. To do this, we generalize the adaptive hierarchical
lasso of Zhou and Zhu (2010) to handle the case of semiparametric models, which is neces-
sary because y may contain components that are not fully observed. In the second stage,
we employ a stepdown procedure analogous to Romano and Wolf (2005) to identify multi-
ple regulation while controlling error rates. Our two-stage testing method, entitled Sparse
Multiple Regulation Testing (SMRT), is powerful for several reasons. First, regularization
enables us to more e ciently estimate both the null and non-null e↵ects. The null e↵ects are
estimated as 0 with probability tending to 1 and the non-null e↵ects are estimated with lower
variability compared to unregularized estimators. Furthermore, the distributions of the esti-
mates of null e↵ects, which tend to a point mass at 0, and the distributions of the estimates
of non-null e↵ects, which tend to exclude 0, are distinctly separated through regularization,
giving us more power to detect the non-null e↵ects (see ﬁgure 1.1 for an illustration from
our simulations). However, it is generally challenging to perform testing based on regular-
ized estimators since their distributions in ﬁnite samples cannot be approximated well by
asymptotic results. We lay out permutation- and resampling-based procedures to better
4approximate the distributions of the proposed test statistics and the regression parameter
estimators. This enables us to properly control error rates for both hypothesis testing and
interval estimation.
The rest of the paper is organized as follows. In section 1.2, we describe the test-
ing procedure. In section 1.3, we discuss estimation using the hierarchical lasso for sparse
semiparametric regression with multiple outcomes, we provide asymptotic properties of the
estimator, and we introduce a method to estimate its variability. In section 1.4, we discuss
issues related to tuning for both estimation and testing. In section 1.5, we apply our method
to a genetic study of autoantibodies with the goal of identifying multiple regulators of au-
toimmunity. We also provide simulation results which validate our method. And ﬁnally, in
section 1.6, we discuss implications and further directions of our method.
1.2 Stepdown testing
Suppose the data for analysis consists of n independent and identically distributed random
vectors V = {Vi =( y
T
i,x
T
i)
T}i=1,...,n where yi =( y
(1)
i ,...,y
(M)
i )
T are the M outcomes and
xi =( xi1,...,x ip)
T are the p predictors for the the ith subject. We assume that
P(y
(m)  y | x)=G
(m){x
T 
(m)
0 + h
(m)(y)} m =1 ,...,M, (1.1)
where  
(m)
0 represents the unknown e↵ect of x on y(m), h(m)(·)i sa nu n s p e c i ﬁ e ds m o o t h ,
increasing function, and the link function, G(m),i sg i v e na l t h o u g ht h ec o r r e l a t i o ns t r u c t u r e
of y is left unspeciﬁed. For ease of presentation, we assume that y is fully observed although
the proposed method can easily accommodate censored outcomes. When y(m) is continuous,
(1.1) is equivalent to
h
(m)(y
(m))= x
T 
(m)
0 + ✏
(m),✏
(m) ⇠ G
(m). (1.2)
For binary or ordinal outcomes, (1.1) and (1.2) are only deﬁned at certain threshold values
and correspond to parametric models. Choice of G(m) determines the type of model being ﬁt.
For example, G(m)(x)=ex/(1+ex)c o r r e s p o n d st oap r o p o r t i o n a lo d d sm o d e lf o rc o n t i n u o u s
y(m) and a logistic regression model if y(m) is binary. One may let G(m)(x)=1  e ex to
impose a proportional hazards model.
5To estimate  
(m)
0 ,o n em a ye m p l o yt h en o n - p a r a m e t r i cm a x i m u ml i k e l i h o o de s t i m a -
tor (NPMLE) under model (1.1) (Zeng and Lin, 2007; Murphy et al., 1997; Murphy and
Van der Vaart, 2000) – or the maximum likelihood estimator if (1.1) corresponds to a para-
metric model – based on data observed on the mth outcome, V(m) = {(y
(m)
i ,x
T
i)
T}i=1,...,n.
Let L(m)( ) denote the resulting proﬁle log-likelihood (PLL) function corresponding to the
NPMLE. It has been shown that under mild smoothness conditions, the proﬁle likelihood can
be treated as a regular likelihood, and the maximum PLL estimator e  
(m)
=a r g m a x   L(m)( )
is regular and semiparametric e cient (Murphy and Van der Vaart, 2000). However, when
p is not too small and { 
(m)
0 }m=1,...,M might be sparse, an improved estimator may be ob-
tained by imposing regularization on the PLL. Let b   denote the regularized estimator of
 0 =(  
(1)T
0 ,..., 
(M)T
0 )
T which we detail in section 1.3. To develop a testing procedure based
on b  , we employ a reference distribution (discussed further in section 1.4) to estimate the
null distribution of b  .
1.2.1 Testing a single predictor xj
In order to make inference on a single predictor, SMRT employs a stepdown procedure for xj
considering the M hypotheses Hj = {H
(m)
j :  
(m)
0j =0 }m=1,...,M with alternative hypotheses
denoted { ¯ H
(m)
j :  
(m)
0j 6=0 }m=1,...,M.
To test H
(m)
j ,w ec o n s i d e rt h et e s ts t a t i s t i ct
(m)
j = n
1
2
     b  
(m)
j
     /e  
(m)
j and its reference
distribution T
(m)
j = {t
⇤b(m)
j }b=1,...,Bwhich approximates the distribution of t
(m)
j under H
(m)
j
and can be obtained by resampling or permutation (see section 1.4). Note that we scale
b  
(m)
j by e  
(m)
j ,w h i c hi sa ne s t i m a t e ds t a n d a r de r r o ro fn
1
2(e  
(m)
j    
(m)
0j ), since under H
(m)
j ,
b  
(m)
j =V a r {n
1
2(b  
(m)
j    
(m)
0j )}1/2 ! 0a n dt h en u l ld i s t r i b u t i o no fn
1
2 b  
(m)
j /b  
(m)
j is di cult to
approximate.
To test Hj simultaneously, we order the test statistics tj =( t
(1)
j ,...,t
(M)
j )
T from largest
to smallest — t
(r1)
j   t
(r2)
j   ...   t
(rM)
j —a n di d e n t i f yt h e i rc o r r e s p o n d i n gh y p o t h e s e s
H
(r1)
j ,...,H
(rM)
j .D e ﬁ n ef o re v e r y⌦⇢{ 1,...,M} the sup-statistic over ⌦ and its correspond-
ing reference distribution: s⌦
j =m a x m2⌦ t
(m)
j and S⌦
j = {maxm2⌦ t
⇤b(m)
j }b=1,..,B.F u r t h e r m o r e ,
denote the  th quantile of S⌦
j by c⌦
j ( ), which approximates the  th quantile of s⌦
j under
6the null that { 
(m)
j =0:m 2 ⌦}.W ei d e n t i f yt h es u b s e to fh y p o t h e s e st or e j e c t ,d e n o t e d
by Rj,a sf o l l o w s .
1) Let ⌦1 = {1,...,M}.I fs
⌦1
j  c
⌦1
j ( ), accept all hypotheses and stop. Otherwise, let
Rj = {r1} and continue.
. . .
k) Let ⌦k =⌦ 1 \ Rj.I f s
⌦k
j  c
⌦k
j ( ), accept all hypotheses in {H
(m)
j }m2⌦k and stop.
Otherwise, let Rj = Rj [{ rk} and continue.
. . .
M) Let ⌦M = {rM}.I fs
⌦M
j  c
rM
j ( ), accept H
(rM)
j .O t h e r w i s e ,l e tRj = Rj [{ rM}.
The step down procedure for the simultaneous testing of Hj then rejects all hypotheses
in {H
(m)
j }m2Rj and concludes that xj is associated with {y(m)}m2Rj.I f t h e p r o b a b i l i t y o f
making a type I error at each step is ↵
P
 
s
⌦k
j >c
⌦k
j ( )
     
\
m2⌦k
H
(m)
j
!
= ↵, for any k
then the FWER of the stepdown procedure – that is, the probability of making at least one
false rejection over the set Hj –i sm a i n t a i n e da t↵.
One of the main results of this paper is that, given a suitably estimated b  , the FWER
of our stepdown procedure approaches 0 as n !1regardless of what quantile   we use to
determine the cuto↵ for rejection. Speciﬁcally, deﬁne A and Ac as indexing the non-zero and
zero components of  0,r e s p e c t i v e l y ,w h e r e A denotes the subvector of   corresponding to
A.F u r t h e r m o r e ,d e ﬁ n easparsistent estimator b   to be one that satisﬁes P(b  Ac =0 )! 1
as n !1 .T h e nw eh a v et h ef o l l o w i n gr e s u l t .
Theorem 1. If b   is sparsistent, then P
⇣
s⌦
j >c ⌦
j ( )
   T
m2⌦ H
(m)
j
⌘
! 0 as n !1for any
⌦ and  , and SMRT has an asymptotic familywise error rate of 0.
The proof is given in Appendix 1.7.1. The result follows from the fact that, under a
given null
T
m2⌦ H
(m)
j ,t h et e s ts t a t i s t i cs⌦
j is estimated at exactly 0 with probability tending
to 1. If s⌦
j =0 ,w ec a n n o tr e j e c t
T
m2⌦ H
(m)
j ,r e g a r d l e s so ft h ev a l u eo fc⌦
j ( ). Of course,
7in ﬁnite samples, choice of   is paramount in maintaining a desired error rate. We discuss
this choice and other tuning issues in section 1.4. In section 1.3, we discuss our estimation
procedure which ensures sparsistency.
1.2.2 Controlling error rates across all predictors
To extend FWER control to the set of all hypotheses {H
(m)
j }j=1,...,p;m=1,..,M,o n ec o u l d
test each Hj at level ↵/p.T h i s m a y b e a c o n s e r v a t i v e s t r a t e g y , a s i t r e l i e s o n a
union-bound argument. Instead, we simply employ a stepdown procedure on all of the
test statistics t =( t
T
1,...,t
T
p)
T.L e t u =( u1,...,u T)
T = t and ˜ H = { e H1,..., e HT} =
{H
(1)
1 ,...,H
(M)
1 ,H
(1)
2 ,...,H
(M)
p } be relabeled test statistics and hypotheses, respectively,
where T = Mp.F u r t h e r m o r e ,d e ﬁ n es⌦ =m a x i2T ui and deﬁne S⌦ and c⌦( )a n a l o g o u s l y
to in the previous section. And ﬁnally let R be the set of rejected hypotheses. Then the
stepdown procedure proceeds exactly as for a single predictor and in the end we reject all
hypotheses { e Hi}i2R.
1.3 Estimation
The aforementioned testing procedure relies on a sparse regularized estimator b   and its
asymptotic properties. We next detail the construction of b   as well as the asymptotic
distribution for the zero and non-zero components, which is crucial for the justiﬁcation of
our proposed testing procedures. Speciﬁcally, we simultaneously consider all M outcomes
and obtain b   as the minimizer of the penalized sum of negative PLLs
 
M X
m=1
L
(m)( 
(m))+p ,w( )( 1 . 3 )
where the penalty function
p ,w( )=
p X
j=1
dj +  
M X
m=1
p X
j=1
w
(m)
j
     ↵
(m)
j
     , with  
(m)
j = dj↵
(m)
j , subject to dj   0,
corresponds to the adaptive hierarchical lasso penalty proposed in Zhou and Zhu (2010) for
grouped predictor variables, penalty parameter   which controls the amount of regulariza-
tion, and weight w
(m)
j = |e  
(m)
j | 1 chosen to ensure oracle properties of b  .S u m m i n g o v e r
8the PLLs in (1.3) essentially imposes a working independence assumption across the out-
comes (Liang and Zeger, 1986). Incorporating covariance information about y can improve
e ciency, which we discuss further in section 1.6. On the other hand, imposing the joint
penalty p ,w( ) incorporates the potential for joint sparsity across all outcomes for some
xj’s. Setting dj =0d e c l a r e sxj to be non-informative for all outcomes or equivalently  0j is
0; while setting ↵
(m)
j =0s u g g e s t st h a t 
(m)
0j =0 .
Now, since {L(m)}m=1,...,M are non-linear functions without closed form in most cases,
direct maximization of (1.3) may be numerically challenging, especially when p is not small.
To overcome these di culties in practice, we propose to take a quadratic expansion of L(m)( )
in (1.3) similar to Zhang and Lu (2007); Wang and Leng (2007). Speciﬁcally, we instead
minimize
PM
m=1( 
(m)   e  
(m)
)
Te I(m)( 
(m)   e  
(m)
)+p ,w( ), which can be re-written as
ke Y   e X k
2
2 + p ,w( ), (1.4)
where e I(m) =   ¨ L(m)(e  
(m)
), ¨ L(m)(b)=@2L(m)(b)/@b@b
T, e X =d i a g (e ⇤
(1)
,...,e ⇤
(M)
), e Y = e Xe  
and e ⇤
(m)
is a symmetric half matrix of e I(m) such that e I(m) = e ⇤
(m)e ⇤
(m)
.T h u s , w e h a v e
reduced the original complicated minimization problem into a penalized L2 minimization
problem, which is much more tractable using widely available software. Computational
simpliﬁcations and a full algorithm for ﬁtting are discussed in appendix 1.7.4.
1.3.1 Asymptotic Theory
In this section, we present the properties of our proposed estimator b  .I t i s s p a r s i s t e n t i n
that it asymptotically sets truly null e↵ects to exactly 0, and our estimates of non-null e↵ects
are asymptotically normal and possess the oracle property,i nt h a tt h e ya r ea se   c i e n ti nt h e
limit as if we knew which e↵ects were truly null a priori.L e tIA,B denotes the submatrix of
I corresponding to rows in A and columns in B.
In Appendix 1.7.2, we show that for PLLs {L(m)( 
(m))}m=1,...,M that satisfy the regular-
ity conditions (also listed in the appendix), if n 1p
  = op(n 1/2), then there exists a root-n
consistent local maximizer b   such that P(b  Ac =0 )! 1a n d
n
1
2(b  A    0A) ! N(0,I
 1
A,A⌃A,AI
 1
A,A)
9in distribution, where ⌃A,A =C o v ( 'iA( 0)), 'iA( A)d e n o t e st h ec o n t r i b u t i o no ft h eith
subject to the proﬁle score function for  A, I =d i a g {I(1),...,I(m)},a n dI(m) is the negative
limiting information matrix corresponding to the proﬁle likelihood for  
(m)
0 .
This result, parallel to that given in Zhou and Zhu (2010), o↵ers the promise of iden-
tifying null e↵ects with probability approaching 1, while still e ciently estimating non-null
e↵ects. From a testing perspective, it motivates theorem 1, and ensures the probability of
making a type I error in SMRT decreases to 0 as n !1 .
1.3.2 Estimating the variability in b  
The asymptotic results on b   suggest that we are as e cient in the limit as if we knew which
parameters were truly 0 from the outset. However, in ﬁnite samples the added variability
due to estimating Ac may not be negligible, and hence relying on the asymptotic result will
underestimate the variability in b  . To better approximate the ﬁnite sample distribution,
we propose a perturbation resampling procedure to estimate the distribution of n
1
2(b     0).
This procedure, by accounting for the variability in estimating Ac,p r o v i d e sam o r ep r e c i s e
estimate of the variability in b  ,a n dm a i n t a i n st h ec o r r e l a t i o ns t r u c t u r ei nb  .
We generate a resampled counterpart of b  ,d e n o t e db yb  
⇤
,i nt w os t e p s .W eﬁ r s tg e n e r a t e
e  
⇤
, a resampled version of e  ,b ye i t h e rp e r t u r b i n gt h en o n - p a r a m e t r i cl i k e l i h o o do rd i r e c t l y
perturbing the inﬂuence function corresponding to e  . Then we minimize our objective
function (1.4) using e  
⇤
in place of e  ,y i e l d i n gr e s a m p l e de s t i m a t e sb  
⇤
.S p e c i ﬁ c a l l y , l e t
G =( G1,...,G n)
T be a vector of iid positive random variables with E[Gi]=1a n dV a r ( Gi)=
1, generated independently of the data. We obtain e  
⇤
as the minimizer of
PM
m=1 L(m)⇤( 
(m))
or explicitly as
e  
⇤
= e   +
n X
i=1
e I
 1e 'i(e  )(Gi   1)
where L(m)⇤( ) is the proﬁle likelihood corresponding to the perturbed non-parametric like-
lihood with the contribution of the ith subject weighted by Gi, e I is the observed information
matrix for   evaluated at e  ,a n de 'i( )i st h ee m p i r i c a le s t i m a t eo ft h es c o r ef u n c t i o n'i( ).
In the second step, we ﬁnd b  
⇤
as the minimizer of Q⇤( )=
PM
m=1( 
(m)  e  
⇤(m)
)
Te I(m)( 
(m) 
e  
⇤(m)
)+
Pp
j=1 dj +  
PM
m=1
Pp
j=1 w
⇤(m)
j |↵
(m)
j | subject to dj   0, w
⇤(m)
j = |e  
⇤(m)
j | 1.S i m i l a r
10resampling procedures have been proposed for making inference with a wide range of stan-
dard objective functions without regularization (Jin et al., 2001; Tian et al., 2007; Uno et al.,
2007, e.g) and recently extended to accommodate L1-type regularized estimators (Minnier
et al., 2011). Here, we propose such a resampling procedure to both account for the po-
tential correlation among the outcomes and better approximate the ﬁnite sample behavior
of hierarchically regularized estimators. Our second main result concerns the asymptotic
properties of the resampled b  
⇤
.
Theorem 2. For PLLs {L(m)( 
(m))}m=1,...,M that satisfy the regularity conditions listed in
the appendix, if n 1p
  = op(n 1/2), then there exists a local maximizer b  
⇤
of Q⇤( ) such
that
(i) kb  
⇤
   0k = Op(n 1/2).
(ii) P
⇣
b  
⇤
Ac =0 |V
⌘
! 1 as n !1
(iii) n
1
2
⇣
b  
⇤
A   b  A
⌘
| V converges in distribution to N(0,I
 1
AA⌃AAI
 1
AA)
The proof is given in appendix 1.7.3. This theorem indicates that, given the observed
data, n
1
2
⇣
b  
⇤
A   b  A
⌘
has the same limiting distribution as n
1
2(b  A    0A). Thus, to ap-
proximate the distribution of b   for a given dataset, we may generate a large number, say
B,o fG,d e n o t e db y{G[b]}b=1,...,B.L e tb  
⇤b
denote the corresponding realization of b  
⇤
.T o
construct a conﬁdence interval (CI) for a speciﬁc  
(m)
j ,o n em a ye s t i m a t et h es t a n d a r de r r o r
of b  
(m)
j as b  
(m)
j the empirical standard error of its perturbed realizations,
n
b  
⇤b(m)
j
o
b=1,...,B
.
An 100(1 ↵)% level conﬁdence interval can then be constructed based on the normal con-
ﬁdence interval b  
(m)
j ±Z 1 ↵/2b  
(m)
j or alternatively the lower and upper ↵/2p e r c e n t i l e so f
n
b  
⇤b(m)
j
o
b=1,...,B
.
1.4 Tuning
In this section, we discuss issues relating to tuning for estimation and testing. First, we
discuss choosing the reference distribution for t
(m)
j for use in testing. Next, we consider the
choice of  , which determines the cut-o↵ for rejection in the stepdown procedure. Finally,
we discuss choosing the penalization tuning parameter  .
111.4.1 Choosing a reference distribution
The reference distribution T
(m)
j = {t
⇤b(m)
j }b=1,...,B needs to approximate the distribution
of t
(m)
j = n
1
2
   
 b  
(m)
j
   
 /e  
(m)
j under H
(m)
j . An immediately appealing choice for the reference
distribution is to use the resampled b  
⇤
,s i n c e ,a sw es t a t e di ns e c t i o n1 . 3 . 2 ,n
1
2
⇣
b  
⇤
A   b  A
⌘
|
V  ! N(0,I
 1
AA⌃AAI
 1
AA). Thus, we could choose t
⇤b(m)
j = n
1
2
     b  
⇤b(m)
j   b  
(m)
j
     /e  
(m)
j . However,
although resampling provides good approximation to the ﬁnite sample distribution of b  A,
it tends to over-estimate the variability of b  Ac. As a result, testing based on T
(m)
j may be
conservative if we choose   =1  ↵.O n ea p p r o a c ht oo v e r c o m et h i si st os e t  at a lower
(less conservative) level – although empirically identifying a proper   to both preserve the
type I error and achieve high power is challenging.
Alternatively, we propose the use of permutation to better approximate the null distri-
butions. Let b  (⌦) = (b  
(m)
j (⌦))j=1,...,p;m=1,...,M denote the estimate of  0 using the dataset
{(y⌦T
i ,x
T
i)
T}i=1,...,n,w h e r e{y⌦
i }i=1,...,n denotes a partially permuted counterpart of {yi}i=1,...n
with {y
(m)
i }m2⌦;i=1,...,n randomly permuted across subjects but {y
(m)
i }m/ 2⌦;i=1,...,n unchanged.
And let b  
b
(⌦) be the bth such permutation-based estimate. To be clear, for example, b  
b
({1})
corresponds to the estimate of  0 from a dataset where only the ﬁrst outcome {y
(1)
i }i=1,...,n
is permuted.
The reference distribution that we pursue in our simulations is a composite dis-
tribution obtained by permuting each of the outcomes individually. For each m,w e
obtain
n
b  
b
({m})
o
b=1,..,B
and retain only those elements which pertain to outcome m:
n
b  
b(m)
j ({m})
o
j=1,...,p;b=1,...,B
.W e t h e n d e ﬁ n e t h e r e f e r e n c e d i s t r i b u t i o n f o r t h e s t e p d o w n
procedure as
t
⇤b(m)
j = n
1
2
   
 b  
b(m)
j ({m})
   
 /e  
(m)
j .
In this way, we are essentially obtaining a reference distribution for (a standardized)
b  
(m)
j under the null hypothesis
T
j=1,...,p H
(m)
j . This strategy has the undesirable consequence
of breaking the correlation structure in y,s i n c et
⇤b(m)
j and t
⇤b(m0)
j are obtained under di↵erent
permutation regimes for m 6= m0.B u td e ﬁ n i n gt
⇤b(m)
j in this way allows us to approximate the
distribution of b  
(m)
j without making any assumption about
T
m06=m H
(m0)
j .T h i sp e r m u t a t i o n
distribution, while not guaranteeing exact control of the FWER, does provide asymptotic
12Figure 1.2: Simulation-based empirical and estimated distribution of null e↵ects. Empirical
null distribution of b  
(m)
j (light purple) agrees closely in the tails with the permutation-based
estimate (dark purple), while the resampling-based estimate (blue-green) overestimates the
density in the tails.
control of the FWER. In our numerical studies, we observe that it does a much better job of
approximating the null distribution of the regularized estimator b   compared to that obtained
based on resampling, as evidenced by ﬁgure 1.2.
1.4.2 Choosing  
In order to control the FWER at the level ↵ for predictor xj with associated hypotheses Hj,
one can choose   =1 ↵.T h i se n s u r e st h a tP
⇣
s
⌦k
j >c
⌦k
j ( )
     
T
m2⌦k H
(m)
j
⌘
= ↵,f o ra n yk,
which in turn ensures FWER control. Similarly, in order to control the FWER across all p
predictors using the union-bound, one can choose   =1  ↵/p for each Hj or perform the
full stepdown procedure on u with   =1  ↵.
If one wanted to use the resampling-based reference distribution with
t
⇤b(m)
j = n
1
2
     b  
⇤b(m)
j   b  
(m)
j
     /e  
(m)
j ,
it is possible to correct for its conservativeness by choosing  <1 ↵,w h i l es t i l lm a i n t a i n i n g
the level ↵. One could use permutation methods or another layer of resampling to estimate
the smallest   that would still maintain the level ↵. However, that requires computing
al a r g en u m b e ro fr e s a m p l e sw i t h i nal a r g en u m b e ro fp e r m u t a t i o n so rr e s a m p l e s ,w h i c h
becomes prohibitively computationally demanding quickly.
131.4.3 Choosing  
SMRT involves a large number of model ﬁts — an equation like (1.4) is minimized once
for each resample or permutation. Each one of those minimizations requires the choice of
the lasso tuning parameter  .B e c a u s eo ft h el a r g en u m b e ro fﬁ t s ,u s i n gat i m e - c o n s u m i n g
method like cross-validation to choose   is not feasible. We propose to use a BIC-style
criteria:
  =a r g m i n
 
⇣
ke Y   e X  k
2
2 +m i n {n
0.1,logn}df 
⌘
,
where    is the minimizer of (1.4) corresponding to   and df  is the number of non-zero
entries in   .I n s m a l l a n d m o d e r a t e s a m p l e s i z e s , n0.1 is much smaller than logn and is
used here. However, when n becomes large logn may be preferred.
1.5 Example
1.5.1 Genetic study to identify shared autoimmune risk loci
We apply our SMRT to a study of shared autoimmunity with the goal of identifying ge-
netic markers associated with 4 autoantibodies: anti-nuclear antibodies (ANA), anti-cyclic
citrullinated protein (CCP) antibodies, anti-transglutaminase (TTG) antibodies, and anti-
thyroid peroxidase antibodies (TPO). These 4 autoantibodies are respectively markers for
4 autoimmune diseases (ADs): systemic lupus erythematosus (SLE), rheumatoid arthritis
(RA), celiac disease and autoimmune thyroid disease. The genetic markers consists of 67
single-nucleotide polymorphisms (SNPs) previously published as potential risk markers for
these four ADs. Discovering which SNPs regulate multiple ADs can aid in understanding
potential shared pathways or etiology of these diseases (Zhernakova et al., 2009). While the
co-occurrence of multiple ADs within individuals has been documented (Somers et al., 2006),
it would be rare, even for someone who is at high risk for the spectrum of ADs, to have more
than one. In contrast, autoantibodies can be present in individuals predisposed to having the
disease even in the absence of a disease phenotype. For example, while co-occurrence of ADs
within families is well documented (Somers et al., 2006), family members of those with au-
toimmune disease may also experience elevated levels of autoantibodies if they haven’t (yet)
14exhibited the disease phenotype. In this study, the autoantibodies are considered markers
for subjects at higher risk for SLE, celiac and autoimmune thyroid disease.
The study cohort includes 1265 individuals of European ancestry with RA identiﬁed
through electronic medical records at Partners Healthcare (Liao et al., 2010; Kurreeman
et al., 2011). Due to a limit of quantiﬁcation, the antibody measurements are highly unreli-
able when the values are either very low or very high. A convenient approach to incorporating
such limitations is by assuming a marginal proportional odds model and truncating the ob-
servations at the limit of quantiﬁcation, which corresponds to (1.1) with ✏(m) coming from a
logistic distribution. Hence  
(m)
0j still has the interpretation of being a log odds ratio (OR).
Results for the autoantibody data are summarized in ﬁgure 1.3. Figure 1.3 (a) shows
results for the sparse estimation step. In the ﬁgure, SNPs are denoted along the y-axis, and
outcomes are denoted along the x-axis. Color of the tile indicates the OR estimate. The
color scale indicates strength and direction of estimated association, with darker red (blue)
colors indicating more positive (negative) association and white indicating no association.
In order to measure the strength of association with respect to the FWER, we adapt the
notion of a q-value (Storey, 2003) for each test to be the smallest ↵ such that that test would
reject while controlling the FWER for that SNP at ↵. Figure 1.3 (b) shows this q-value for
each test.
For such a large number of total hypotheses, we do not have su cient power to detect
multiple regulation while simultaneously controlling the familywise error rate across all SNPs.
Taking a less conservative view, if we control the FWER at the SNP level, ﬁve SNPs show
some evidence of multiple regulation at ↵ =0 .1. The SNP rs2187668, which had previously
shown associations to SLE (Taylor et al., 2011) and celiac (van Heel et al., 2007), we estimate
to be related to the autoantibodies for those diseases at OR = 1.45 (q-value 0.005) for ANA
and OR = 1.62 (q-value 0.005) for TTG, as well as to CCP (OR = 0.78, q-value 0.05). This
SNP is in the MHC region, which is known to a↵ect immune function. Similarly, rs3129860,
also in the MHC region, which had previously shown an association to SLE (Taylor et al.,
2011), here demonstrated an association to ANA (OR = 1.28, q-value 0.05), CCP (OR =
1.50, q-value 0.003), and TPO (OR = 1.30, q-value 0.05). After having previously been
15associated with both autoimmune thyroid disease (Ueda et al., 2003) and RA (Plenge et al.,
2005), rs3087243, which is located in the CTLA4 gene, was found to be associated with
CCP (OR = 1.18, q-value 0.06) and TTG (OR = 1.22, q-value 0.07). And rs4963128 was
similarly associated with CCP (OR = 0.85, q-value 0.06) and TTG (OR = 1.23, q-value
0.06), having been associated with SLE in previous studies (Harley et al., 2008). Finally,
rs6679677, located on gene RSBN1, displayed as association with CCP (OR = 1.32, q-value
=0 . 0 2 )a n dT T G( O R=1 . 2 9 ,q-value = 0.10), after having previously been identiﬁed as
associated with RA (Burton et al., 2007) and hyperthyroidism (Eriksson et al., 2012).
1.5.2 Simulation results
We ran simulations to assess the performance of our point and interval estimation procedures
as well as SMRT. We loosely based our simulations on the autoantibody dataset, allowing the
relationship between x and y to be speciﬁed by a proportional odds model. We considered
sample sizes of 150, 250, and 500 and ran 1000 simulations for each sample size. For each
simulation, 1000 resampled b  
⇤
sw e r eg e n e r a t e d .
We set the number of predictors of interest p to be 30 and the number of outcomes
M to be 4. Covariates x took values in {0,1,2} with probability {p2,2p(1   p),(1   p)2}
where p =0 .15. Outcomes y were generated according to the marginal proportional odds
model, conditional on x.W e a l l o w e d c o r r e l a t i o n i n y,w h i c hw a sa c c o m p l i s h e db yﬁ r s t
generating correlated normal random variables zi ⇠ N4(0,⌃) where ⌃ = 0.85I +0 .1511
T is
exchangeable. Then let ui =  ( zi)f o rG a u s s i a nd i s t r i b u t i o nf u n c t i o n  ( ·), and ﬁnally
yi =e x p {xi 0 + ✏i}
where ✏i =l o g (
ui
1 ui) ⇠ logistic. For computational simplicity, we discretized y into ten
levels.
The relationship between x and y is deﬁned by
[ 
(1)
0 ,..., 
(M)
0 ]=

120
1
216 112
1
28
010 014 018 022
 
30⇥4
.
where 1k is a k ⇥ 1v e c t o ro fo n e s ,0k =0⇥ 1k and 1
2k = 1
2 ⇥ 1k.
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Figure 1.3: Results for autoantibody data. SNPs are listed on the y-axis, and autoantibodies
are listed on the x-axis. (a) Sparse e↵ect estimates. The color of the rectangle indicates the
e↵ect. Red indicates positive association (OR > 1) between SNP and autoantibody; blue
indicates negative association (OR < 1). Darker colors indicate larger magnitudes, and white
indicates no estimated association. (b) q-values. Darker color indicates smaller q-value and
more evidence against the null hypothesis of no association.
17This conﬁguration indicates that there are eight predictors related to all four outcomes,
four related to just the ﬁrst three outcomes, four related to just the ﬁrst two outcomes, and
four related to just the ﬁrst outcome. The remaining ten predictors are null, unrelated to
any outcome. We also see that associations to outcomes y(2) and y(4) are weak, so we would
expect there to be less power to detect those e↵ects.
1.5.3 Bias, standard errors (SEs), and conﬁdence intervals (CIs)
We ﬁrst demonstrate that our point and interval estimation procedures perform well in ﬁnite
samples. Figure 1.4 shows the average bias in b   and e   across simulations, plotted according
to true e↵ect size  0 and sample size. The regularized b   exhibits much smaller bias than
the unregularized e   for all sample sizes and e↵ect sizes. Particularly at smaller sample sizes,
regularization substantially reduces the bias in the estimator.
In ﬁgure 1.5, we plot the average percent bias in SE estimates obtained based on our
proposed resampling procedures as well as those based on the asymptotic variance. Both
the asymptotic SE estimate and the resampling-based one b  
(m)
j overestimate the variability
in b  
(m)
j when  
(m)
0j = 0, but b  
(m)
j more closely approximates  
(m)
j . When  
(m)
0j 6= 0, the
asymptotic SE tends to underestimate the true variability, while b  
(m)
j approximates it well.
We examine CI coverage in ﬁgure 1.6 and see that underestimating the SEs leads to
poor 95% CI coverage levels for the normal-based CI methods, based on e  
(m)
j and b  
(m)
j .
Resampling-based quantile 95% CIs have good coverage for all values of  
(m)
0j and all sample
sizes. The coverage levels of asymptotic-based CIs are as low as 78% for non-zero e↵ects and
remain lower than the nominal level even when n = 500. Hence in practice, we recommend
the quantile based CIs.
1.5.4 Testing
In this section, we examine the performance of our proposed testing procedures. To demon-
strate the role of regularization in improving testing, we compare SMRT to an unregularized
version, which we will call MRT. Throughout we use the permutation method outlined in
section 1.4.1 as the reference distribution for both SMRT and MRT and take   =1 ↵.T o
18Figure 1.4: Average estimated bias in regularized b  
(m)
j and unregularized e  
(m)
j across 1000
simulations plotted against  
(m)
0j .R e s u l t s f o rb   are depicted on the left and for e   on the
right. Color denotes sample size. Bias estimates are aggregated over all estimates that share
the same e↵ect size.
Figure 1.5: Average estimated bias of estimates of  
(m)
j the SE of b  
(m)
j across 1000 simula-
tions, arranged according to value of  
(m)
0j . Results for the asymptotic SE are on the left, and
those for the resampling-based b  
(m)
j are on the right. Bias was estimated as the di↵erence
between the empirical SE of b  
(m)
j across simulations and the estimated one. Bias estimates
are aggregated over all estimates that share the same e↵ect size. Color denotes sample size.
19Figure 1.6: 95% CI coverage across 1000 simulations arranged according to value of  
(m)
0j .
Results for normal-based CIs based on asymptotic SEs are depicted in the left panel, normal-
based CIs based on b  
(m)
j in the middle panel, and CIs based on quantiles of b  
⇤(m)
j in the right
panel. Coverage estimates are aggregated over all estimates that share the same e↵ect size.
Color denotes sample size.
demonstrate the advantages of using the stepdown method, we compare also to a single-step
procedure, which we will denote Sup in the following, where we reject all H
(m)
j for which
t
(m)
j >c
⌦1
j ( ), where as before ⌦1 = {1,...,M}. Finally, we compare to the Bonferroni
adjustment by computing the asymptotic p-values p
(m)
j =2  
⇣
 
     b z
(m)
j
     
⌘
and rejecting H
(m)
j
if p
(m)
j < ↵
Mp.
When controlling the FWER at ↵ =0 .05 for each SNP, SMRT and MRT performed
similarly in controlling FWER. For n = 250, the average empirical FWER was 0.055 for
SMRT and MRT. The more conservative Sup test had average FWER of 0.039, and the
even more conservative Bonferroni 0.003. All three of SMRT, MRT, and the Sup test had
empirical FWER for one SNP as high as 0.07 (0.077 for MRT, 0.072 for SMRT and Sup).
Results for other sample sizes were similar.
In terms of power, SMRT dominates all other test procedures. Figure 1.7 depicts the
power to detect non-null e↵ects at n =2 5 0( o t h e rs a m p l es i z e ss h o ws i m i l a rr e l a t i v ep e r -
formances, with SMRT performing relatively better as sample size decreases). Tests of the
form {H0 :
S
 
(m)
j =0 } are listed across the bottom, and results are arranged according to
how many outcomes the predictor is actually associated with. The ﬁgure shows that SMRT
is uniformly more powerful than MRT, Bonferroni and Sup, with the di↵erences becoming
20more apparent in identifying multiple regulation.
The above describes the results for testing a single predictor xj with associated hy-
potheses Hj. Results for controlling the FWER across all predictors and all hypotheses were
qualitatively similar. SMRT maintained the nominal level of the test and obtained higher
power than MRT, Sup, and Bonferroni at all sample sizes.
1.6 Discussion
We have proposed a framework for testing and estimation across a diverse set of outcomes.
This framework allows the combination of information across continuous, semi-continuous,
and discrete outcomes while maintaining control of the FWER for each predictor or across
all predictors. It is ﬂexible to the type of marginal likelihood speciﬁed and can easily in-
corporate more complex data structures such as censored survival outcomes. We rely on
sparse estimation via penalization in our testing procedure. Many penalty functions could
potentially accomplish similar results to the hierarchical penalty we proposed. As long as
sparsistency holds and a suitable reference distribution can be obtained through permutation
or resampling, other penalty functions could be worth exploring.
For simplicity, we used a working independence assumption to combine the proﬁle log-
likelihoods of multiple outcomes. But when the outcomes are not independent, incorporating
information about the covariance in y can improve e ciency (Liang and Zeger, 1986). A
further advantage to using the quadratic approximation to L(m) in (1.4) instead of the proﬁle
log-likelihood itself (besides computational tractability) is that we can incorporate covariance
information about y through the initial estimate e  .I ft h e( u n p e n a l i z e d )i n i t i a le s t i m a t ee  
is estimated in a way that gains e ciency by taking correlation in y into account, then that
increase in e ciency will be propagated into our estimation of b  .
Finally, we have focused on FWER as the error rate of primary interest throughout this
paper, but we could easily extend our framework to include more generalized error rates,
such as k-FWER or the false discovery proportion, as in (Romano et al., 2010). We focus
on FWER here because inference on a single predictor xj when the number of outcomes M
is not large likely calls for control of FWER. However, in some situations – especially when
21Figure 1.7: Power to detect non-null e↵ects across 1000 simulations at sample size n =2 5 0 .
Each plot indicates how many outcomes the predictors tested are associated with. For
example, the top left plot corresponds to predictors with strong association to y(1),  
(1)
0j =1
and weak association to y(2),  
(2)
0j =0 .5. Tests are listed on the x-axis. Power is indicated
on the y-axis. Power estimates are aggregated over all estimates that share the same e↵ect
sizes. To take a couple of examples, the bar corresponding to ”y1” in the ﬁgure corresponds
to power to reject H
(1)
j , and the bar corresponding to ”y1/y2/y3” in the ﬁgure corresponds
to power to reject each of H
(1)
j ,H
(2)
j ,H
(3)
j simultaneously.
22the total number of tests T is large – one may desire to control a less restrictive error rate.
1.7 Appendix
For the following proofs, we put mild restrictions on the model (1.1) for each outcome
y(m), as described in section 3 of Murphy and Van der Vaart (2000). We reproduce the
restrictions here for completeness. Since the requirements hold for each outcome, we drop
the superscripts (m) for the moment. Let logl( ,h)(x) be the full log-likelihood. We require
that there exists a ht( ,h)s u c ht h a t`(t, ,h)(x)=l o gl(t,ht( ,h))(x)i st w i c ec o n t i n u o u s l y
di↵erentiable for all x with ﬁrst and second derivatives denoted ˙ `(t, ,h)(x)a n d¨ `(t, ,h)(x).
Further, h ( ,h)=h,for every ( ,h). And ˙ `( 0, 0,h 0)m u s tb et h ee   c i e n ts c o r ef u n c t i o n .
For every ﬁxed  ,l e tb h  be the NPMLE for h.T h e n , f o r a n y  
† !p  0, b h † !p h0 and
E
h
˙ `( 0, 
†,b h †)
i
= op(k 
†  0k+n 1/2). Finally, suppose that there exists a neighborhood
W of ( 0, 0,h)s u c ht h a t{˙ `(t, ,h):( t, ,h) 2W }is Donsker with square integrable
envelope function and {¨ `(t, ,h):( t, ,h) 2W}is Glivenko-Cantelli and bounded in L1.
1.7.1 Justiﬁcation of stepdown procedure
In this section, we will show that, when using an estimator that satisﬁes P(b  Ac =0 )! 1,
the testing procedure for each of the set of hypotheses {Hj}j=1,..,p delineated in section 1.2
has FWER converging to 0 for any choice of   2 [0,1].
First we show that the stepdown procedure for Hj has FWER converging to 0. Goeman
and Solari (2010) show that two conditions need to be satisﬁed in order for a sequentially
rejective procedure of this sort to control the FWER at a given level ↵. First, a monoticity
condition requires that the threshold for rejection must not increase as the test proceeds.
That is, for ⌦k0 ✓ ⌦k:
c
⌦k
j ( )   c
⌦k0
j ( ). (1.5)
This condition is guaranteed by construction. Consider for any j, any element of S
⇤⌦k
j ,
m
⇤⌦k
j ⌘ maxm2⌦k t
⇤(m)
j 2 SKj and the corresponding element of S
⌦k0
j , m
⇤⌦k0
j .S i n c e⌦ k0 ⇢ ⌦k,
m
⇤⌦k
j   m
⇤⌦k0
j ,
23which in turn implies (1.5). Second, a single-step condition requires that the thresholds
must be chosen so as to control type I error at ↵ in the critical case,w h e nt h es e to f
candidate hypotheses are all null. That is, recalling that R0j is the set of indices of all true
null hypotheses, P
⇣
S
R0j
j >c
R0j
j ( )
⌘
 ↵. Because P(b  Ac =0 )! 1, any choice of   will
be su cient. That is, for any  , P
⇣
s
R0j
j >c
R0j
j ( )
⌘
! 0b e c a u s eP(s
R0j
j =0 )! 1a n d
c
R0j
j ( )   0f o ra n y . Thus, our testing procedure will control the FWER for each predictor
xj asymptotically at any level ↵ for any choice of  .S i n c ew ec a nc h o o s e↵ as small as we
want, the FWER for the set of hypotheses Hj converges to 0.
1.7.2 Proof of sparsistency and asymptotic normality
To state and prove the results, we will need some preliminaries. Our objective function can
be written equivalently as solely a function of   rather than as a function of ↵
(m)
j and dj,
as shown in Theorem 1 of Zhou and Zhu (2010). For a ﬁxed number of outcomes and ﬁxed
number of predictors, the objective function can be written
Q( )=ke Y   e X k
2
2 + n n
p X
j=1
n M X
m=1
w
(m)
j | 
(m)
j |
o1/2
(1.6)
where n n =
p
 .
We ﬁrst show the root-n consistency of our estimator b   in the following lemma, which
is used in the proof of sparsistency and asymptotic normality.
Lemma 1. (Root-n consistency) For PLLs {L(m)( 
(m))}m=1,...,M that satisfy the regular-
ity conditions listed above, if  n = Op(n 1/2), then there exists a local maximizer b   of Q( )
such that kb      0k = Op(n 1/2).
Proof. Let Q( )=
PM
m=1( 
(m)   e  
(m)
)
Te I(m)( 
(m)   e  
(m)
)+p n,w( ). We will show that
for a given ⌧>0, c =m i n j,m{| 
(m)
0j | :  
(m)
0j 6=0 } there exists a constant C such that
24P[supkuk=C Q( 0 + n 1/2u) >Q ( 0)]   1   ⌧. Now consider
D(u)=Q( 0 + n
 1/2u)   Q( 0)=
M X
m=1
( 
(m)
0 + n
 1/2u   e  
(m)
)
Te I
(m)( 
(m)
0 + n
 1/2u   e  
(m)
)
 
M X
m=1
( 
(m)
0   e  
(m)
)
Te I
(m)( 
(m)
0   e  
(m)
)+n
 
p n,w(| 0 + n
 1/2u|)   p n,w(| 0|)
 
= n
 1/2u
Te I( 0   e  )+
n 1
2
u
Te Iu   n
 
p n,w(| 0 + n
 1/2u|)+p n,w(| 0|)
 
=( I)+( II)+( III)
Now, since ke I(m) nI(m)k = op(1), then ke I nIk = op(1), and (I)=n
1
2u
TI( 0 e  )[1+op(1)] 
Op(1)kukkIk.F u r t h e r m o r e , ( II)=u
TIu[1 + op(1)]  Op(1)kuk2kIk. Now, following the
argument in Zhou and Zhu (2010), (III)  Op( nn
1
2). Thus, as long as  n = Op(n 1/2),
all terms are dominated by the ﬁrst term of (II), which is positive. And the proof is
concluded.
We will now show that b   is sparsistent: P
⇣
b  Ac = 0
⌘
! 1. If we can show that
@Q( )
@ 
(m)
j
=
Op(n
1
2)+n
@p n,w( )
@ 
(m)
j
then sparsistency follows from lemma 1 and the argument in the proof
of Theorem 4 in Zhou and Zhu (2010). To this end, note that
@Q( )
@ 
(m)
j
=(  
(m)   e  
(m)
)
Te I
(m)
j + n
@p n,w( )
@ 
(m)
j
=(  
(m)
0   e  
(m)
)
Te I
(m)
j +(  
(m)    
(m)
0 )e I
(m)
j + n
@p n,w( )
@ 
(m)
j
= Op(n
1
2)+n
@p n,w( )
@ 
(m)
j
for any   satisfying k     0k = Op(n 1/2), noting that e I
(m)
j = Op(n)f o ra l lj,m. And thus
sparsistiency P(b  Ac = 0) ! 1f o l l o w s .
Next we consider asymptotic normality. Let  (A)d e n o t e  with elements not in A
set to 0. Because we have sparsistency, b  (A)i sar o o t - n consistent minimizer of Q( ), and
rQ{b  (A)} = op(1). Thus, minimizing Q{ (A)} is asymptotically equivalent to minimizing
QA( A)=( A   e  A)
Te IA,A( A   e  A)   ( A   e  A)
Te IA,Ace  Ac + np n,w( A)] where e I⌦1,⌦2
denotes the submatrix of e I corresponding to rows in ⌦1 and columns in ⌦2.I tf o l l o w st h a t
op(1) = rQA(b  A)=e IA,A(b  A   e  A)  e IA,Ace  Ac + rnp n,w(b  A)
= e IA,A(b  A    0A)+e IA,A( 0A   e  A)  e IA,Ace  Ac + rnp n,w(b  A)
25and hence
n
1
2(b  A    0A)=n
1
2(e  A    0A)   n
1
2e I
 1
A,Ae IA,Ace  Ac + n
1
2(ne I
 1
A,A)rp n,w(b  A)
=( ne I
 1
A,A)n
  1
2
n X
i=1
'iA( 0)+n
1
2(ne I
 1
A,A)rp n,w(b  A)+op(1)
This, together with the same argument as in the proof of Theorem 4 in Zhou and Zhu (2010),
rp n,w(b  A)=op(n  1
2), implies that n1/2(b  A    0A)=n 1/2I
 1
A,A
Pn
i=1 'iA( 0)+op(1).
1.7.3 Properties of resampled b  
⇤
Let P⇤ be the measure generated by both V and G. First, note that
     e  
⇤
   0
      =
         
e   +
n X
i=1
e I
 1e 'i(e  )(Gi   1)    0
       
 

     e      0
      +
       
 
n X
i=1
e I
 1e 'i(e  )(Gi   1)
       
 
= OP⇤(n
 1/2)+
     
   
1
n
n X
i=1
n
ne I
 1e 'i(e  )
o
(Gi   1)
     
   
Noting that G is independent of V, E[Gi   1] = 0, and E[I 1e 'i(e  )] < 1,
1
n
Pn
i=1{ne I 1e 'i(e  )}(Gi   1) !P⇤ 0a n dt h ep e r t u r b e di n i t i a le s t i m a t ei sa l s or o o t - n con-
sistent:
     e  
⇤
   0
      = OP⇤(n 1/2).
Moreover, for the root-n consistency proof of b  ,t h er o l eo fe   in Q( )i so n l yt h a to fa
root-n consistent initial estimate. Inspection of the proof of b  ’s root-n consistency will show
that the only fact about e   that we need is
   
 e      0
   
  = Op(n 1/2). Therefore, in just the same
way, root-n consistency of e  
⇤
gives us root-n consistency of b  
⇤
:
     b  
⇤
   0
      = OP⇤(n 1/2).
Now, sparsistency of b  
⇤
| V follows from a similar argument as for sparsistency of b  .C o n s i d e r
@Q⇤( )
@ 
(m)
j
         
V =(  
(m)   e  
⇤(m)
)
Te I
(m)
j + n
@p n,w⇤( )
@ 
(m)
j
         
V = OP⇤(n
1
2)+n
@p n,w( )
@ 
(m)
j
         
V
for any   satisfying k   0k = OP⇤(n 1/2), noting that
Pn
i=1(Gi  1) = OP⇤(n
1
2). And thus
sparsistency follows: P
⇣
b  ⇤
Ac = 0
 
   V
⌘
! 1.
Finally, following the logic in the proof of asymptotic normality of b  ,
n
1
2(b  
⇤
A    0A)=n
1
2(e  
⇤
A    0A)   n
1
2e I
 1
A,Ae IA,Ace  
⇤
Ac + oP⇤(1) = n
1
2K(e  
⇤
   0)+oP⇤(1)
26for K = dA e I
 1
AAe IAAcdAc,d A  =  A, and dAc  =  Ac.I nt h ep r o o fo fa s y m p t o t i cn o r m a l i t y
of b  ,w es h o w e dt h a tn1/2K(e    0)=n 1/2I
 1
AA
Pn
i=1 'iA( 0)+oP⇤(1). Note that n
1
2K(e   
 0)=n
1
2Ke I 1 Pn
i=1 e 'i(e  )+oP⇤(1), which suggests
n
1
2(b  
⇤
A    0A)=n
 1/2I
 1
AA
n X
i=1
'iA( 0)(Gi   1) + n
1
2K(e      0)+oP⇤(1)
And recall from above that n1/2(b  A    0A)=n 1/2I
 1
A,A
Pn
i=1 'iA( 0)+oP⇤(1) = n
1
2K(e    
 0)+oP⇤(1). Then, let Zi = n 1/2I
 1
AA'iA( 0)(Gi  1), so that E[Zi|V]=0a n dC o v [ Zi|V]=
n 1I
 1
AA'iA'
T
iAI
 1
AA ⌘  i.B e c a u s e
Pn
i=1 E[k 
 1/2
i k3
2|V]=oP⇤(1), then by the argument in
Bentkus (2005), n
1
2(b  
⇤
A   b  A)
 
   V !L N(0,I
 1
AA⌃AAI
 1
AA).
1.7.4 Algorithm
An iterative procedure can be employed to ﬁt the model (1.4). First, ﬁx d and estimate
↵ via adaptive lasso. Next, ﬁx ↵ and estimate d using the nonnegative garrote. However,
because of the widespread availability and speed of lasso-type estimation, we in general
prefer to employ adaptive lasso to the nonnegative garrote. So we propose to estimate d
using adaptive lasso as well, by minimizing the following objective function
ke Y   e X k
2
2 +
p X
j=1
|dj| +  
M X
m=1
p X
j=1
w
(m)
j |↵
(m)
j |, (1.7)
Using the adaptive lasso in place of the nonnegative garrote is justiﬁed here by the argument
in Zou (2006) that the adaptive lasso is asymptotically equivalent to the nonnegative garrote.
That is, the nonnegative garrote is equivalent to the adaptive lasso with a further sign
constraint, and the sign constraint is satisﬁed (at least in the limit) by consistency of the
adaptive lasso. Our iterative ﬁtting procedure, then, uses the adaptive lasso at both stages
and is thus very fast.
Fitting the model can proceed as follows:
1. Set d(0) = 1 and e X  = e Xdiag(|e  |). Let k =1 .
2. Update ↵.S e tD↵ =d i a g ( d(k 1))a n de X↵ = e X diag(D↵,...,D ↵)Mp⇥Mp and obtain
↵(k) =a r g m i n
↵
ke Y   e X↵↵k
2
2 +  
M X
m=1
p X
j=1
|↵
(m)
j |
27Inclusion of e   in e X↵ is equivalent to using weights w
(m)
j = |e  
(m)
j | 1.
3. Update d.S e te Xd = e XAd where Ad =
2
6 6 6 6
4
diag(↵
(1)
(k))p⇥p
diag(↵
(2)
(k))p⇥p
. . .
diag(↵
(M)
(k) )p⇥p
3
7 7 7 7
5
Mp⇥p
Then,
d(k) =a r g m i n
d
ke Y   e Xddk
2
2 +
p X
j=1
|dj|
4. Update  .
 
(m)
j(k) = dj(k)↵
(m)
j(k)|e  
(m)
j |
.
5. Iterate until convergence.
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292.1 Introduction
In recent years, considerable interest has been focused on studying multiple phenotypes
simultaneously in both epidemiological and genomic studies. Such studies are important
for several reasons. First, a complex disorder is usually associated with multiple correlated
phenotypes. Hence, even when a study is focused on a speciﬁc disease, multiple phenotypes
might be needed to fully capture the complexity and multidimensionality of the disorder.
Second, multiple related disorders might share the same etiology and a joint assessment will
enable identifying subpopulations which might be at high risk of multiple diseases.
For example, hypertension, type 2 diabetes, and cardiovascular diseases are common
chronic conditions that tend to occur in the same individual, suggesting common predis-
posing factors (Cheung, 2010). Established common environmental factors that predispose
to these diseases include obesity and physical activity. Individuals with abdominal obesity
are likely to develop lipid abnormalities and elevation of blood pressure and glucose. In
time, hypertension, diabetes and cardiovascular disease ensue. For psychiatric disorders,
many diseases also are associated with childhood adversities, suggesting shared environmen-
tal roots (Kessler et al., 1997; Green et al., 2010). Recent genetic studies have suggested
that many genetic loci appear to harbor variants associated with multiple traits (Solovie↵
et al., 2013). For example, genetic epidemiological studies have documented that schizophre-
nia, bipolar disorder, and major depressive disorder share familial and genetic determinants
(Smoller et al., 2013). As another example, recent studies have identiﬁed common genes as-
sociated with a higher risk of what were previously considered distinct autoimmune diseases
(Zhernakova et al., 2009; Xavier and Rioux, 2008).
When multiple related disorders share common genetic and/or environmental factors,
one may question whether these disorders are etiologically distinct. If these disorders do have
a shared etiology, it is possible to identify a new common underlying trait and examine how
well known risk factors can explain the underlying trait. If a risk proﬁle can be developed to
accurately predict such a trait, prevention and treatment strategies can then be developed
to better manage the disorders.
A useful approach to address such questions is the canonical correlation analysis (CCA)
30(Hotelling, 1936; Thompson, 1984; Hardoon et al., 2004). In CCA, traits and risk proﬁles
are identiﬁed as a
T
1y and b
T
1x,r e s p e c t i v e l y ,v i at h em a x i m i z a t i o np r o b l e m
argmax
a,b
cor(a
Ty,b
Tx), (2.1)
for vector of phenotypes y =( ym)1mM and vector of predictors x =( xj)1jp subject
to a constraint on the norms of a and b for identiﬁability. Additional projections pairs
(ak,bk)k>1,o r t h o g o n a lt o( a1,b1)a n de a c ho t h e r ,c a na l s ob es e q u e n t i a l l yi d e n t i ﬁ e dt o
capture residual correlations between the outcomes and predictors. However, since the phe-
notypes quantifying di↵erent disorders are often of di↵erent scales, identifying traits as linear
combinations of y may not be appropriate or possible. For example, when the outcomes are
measurements of biomarkers for one autoimmune disease, the measurements of one biomarker
may be orders of magnitude larger or smaller than the measurements for another biomarker.
Hence, transformations of the outcomes are needed in order to put them onto the same scale
and relate them to the predictors. Furthermore, when some outcomes are subject to censor-
ing or truncation, the traditional CCA is also not applicable since the relevant covariances
are not identiﬁable without modeling. As an example, the biomarkers for some disorders
like autoimmune disease may be subject to limits of quantiﬁcation above and below which
the true measurement of the biomarkers are unavailable.
Various extensions of CCA have been proposed in recent years. Other measures of
association beyond Pearson’s correlation coe cient (Jin and Cui, 2010) and semiparametric
single-index models (Xia, 2008) have been proposed to account for nonlinearity between the
traits and risk proﬁles, but these methods still require that traits be linear combinations of
y. In the setting of fully observed, continuous y,( Z h ue ta l . ,2 0 0 7 )p r o p o s e st oe s t i m a t e
transformations of y via smoothing and goes on to perform partial least squares, a close
relative of CCA. No methods have yet been proposed for our situation where y may be
diverse –t h a ti s ,y may contain components that are continuous, discrete, and/or not fully
observed due to censoring or truncation.
We propose semiparametric canonical correlation analysis (sCCA) to identify projection
pairs (ak,bk)k 1 where now traits are conceived as a
T
kh where h is a vector of transformed
(possibly latent) phenotypes, all of which are on the same scale. We identify the projection
31pairs via a three-stage procedure. The ﬁrst stage involves marginal models that put all
phenotypes on the same scale by conceiving of each ym as a possibly thresholded or truncated
observation of a smooth latent variable zm. We use semiparametric transformation models
for continuous or censored ym and parametric models for discrete ym.I nt h es e c o n ds t a g e ,
we characterize the covariance matrix of h using copula methods in conjunction with the
estimates from the marginal models. Copulas have been used in similar modeling situations
for survival data (Othus and Li, 2010) and discrete data (Xue-Kun Song, 2000). And ﬁnally
we perform CCA using the results from the copula and marginal models to identify the sCCA
projection pairs. Note that the target of estimation is the set of projection pairs, not the
traits themselves. By obtaining the projection pairs, we can obtain the risk proﬁles (b
T
kx)k 1,
but since h may involve the unobservable zm,w em a yn o tr e c o v e rt h et r a i t s( a
T
kh)k 1 even
when we can recover the trait directions (ak)k 1.
The structure of the rest of the paper is as follows. In section 2.2, we introduce sCCA
and discuss its properties. In section 2.3, we apply sCCA to a genetic study to identify risk
proﬁles for autoimmune disease, and we provide simulation results. Finally, in section 2.4,
we provide a discussion of the method.
2.2 Semiparametric canonical correlation analysis
Suppose the data for analysis consists of n independent and identically distributed random
vectors V = {Vi =( y
T
i, 
T
i,x
T
i)
T}i=1,...,n where yi =( yi1,...,y iM)
T is a set of M phenotypes,
 i =(  i1,...,  iM)
T is a set of M censoring indicators, and xi =( xi1,...,x ip)
T is a set of p
predictors for the the ith subject.
Recall that, if we were interested in traits of the form a
T
ky,w ew o u l ds e e kt oo b t a i n
(2.1), or equivalently,
argmax
a,b
a
T⌃yxb, subject to a
T⌃yya = b
T⌃xxb =1
where ⌃wv =C o v ( w,v). However, due to the components of y being incompletely observed
or measured on incomparable scales, identifying traits as linear combinations of y does not
32make sense. Instead, we consider traits to be of the form a
T
kh and we thus obtain
(a1,b1)=a r g m a x
a,b
a
T⌃hxb, subject to a
T⌃hha = b
T⌃xxb =1 . (2.2)
Additional directions (ak,bk)c a nb eo b t a i n e db ys o l v i n g( 2 . 2 )w i t ht h ea d d i t i o n a lc o n s t r a i n t s
that (a
T
kaj = b
T
kbj =0 ) 1j<k. Another quantity of interest is the proportion of variance
explained rk =t r ( ⌃ hhak⇢2
ka
T
k⌃hh)/tr(⌃hh)( G l a h n ,1 9 6 8 )w h e r e⇢k =c o r ( a
T
kh,b
T
kx).
Thus the parameters of interest, ✓ =( ak,bk,r k)1kK can be expressed as functions of
  =( v e c ( ⌃ xx)
T,vec(⌃hx)
T,vec(⌃hh)
T)
T
✓ = g( ). (2.3)
And we estimate g( ) by simply plugging in suitable consistent estimators
b ✓ = g(b  ).
In section 2.2.1, we identify h,⌃ hh,a n d⌃ hx,a n di ns e c t i o n2 . 2 . 2w et a k eu pe s t i m a t i o n .
2.2.1 Identifying h
Since the diversity of y causes its components to be on incomparable scales and possibly
unobserved, we ﬁrst identify possibly latent continuous variables z =( zm)1mM whose
components can be put on comparable scales. The relationship between the observed ym
and the latent zm can be described as follows. If yim is continuous and uncensored ( im =0 ) ,
then yim = zim.I fyim is continuous and censored ( im =1 ) ,t h e nyim  zim.F o rd i s c r e t e
outcomes, we consider ym to be a thresholded version of zm such that, if ym,w i t h o u tl o s so f
generality, takes values in the set Ym = {0,1,...,K m} then
yim =
8
> <
> :
0,z im  0
k, zim 2 (k   1,k], 1  k  Km   1
Km,z im >K m   1.
We assume that the marginal distribution of zm follows the following model
P(zm  z | x)=gm{x
T m0 + hm0(z)}, (2.4)
33where  m0 represents the unknown e↵ect of x on zm and the link function, gm(·), is given
although the correlation structure of z (and thus y) is left unspeciﬁed. The transformation
hm0(·)i sa ni n ﬁ n i t e - d i m e n s i o n a l ,u n s p e c i ﬁ e d ,s m o o t h ,i n c r e a s i n gf u n c t i o ni fym is continuous,
while it is a ﬁnite-dimensional function on the set {0,...,K m 1} if ym is discrete. Choice of gm
determines the type of model being ﬁt. Some practical examples include gm(x)=ex/(1+ex),
corresponding to a proportional odds model for continuous ym and a logistic regression model
if ym is binary. One may let gm(x)=1  e ex to impose a proportional hazards model.
The model (2.4) is equivalent to
hm0(zm)= x
T m0 + ✏m,✏ m ⇠ gm. (2.5)
In this representation, it is clear that the components of h =( hm0(zm))
T
1mM are on com-
parable scales, as each is expressed as a linear combination of x and an independent error.
We deﬁne
⌃hh =C o v ( h,h)=B
T
0⌃xxB0 +⌃ ✏✏ and ⌃hx =C o v ( h,x)=⌃ xxB0, (2.6)
where B0 is a K ⇥ p matrix with columns  m0 and ⌃✏✏ =C o v ( ✏,✏),✏ =( ✏m)1mM.
2.2.2 Estimating the joint distribution
In order to estimate  ,w em u s tp r o v i d ee s t i m a t e so f⌃ xx,⌃hx, and ⌃hh.E s t i m a t i o no f⌃ xx
may proceed in the usual fashion, using
b ⌃xx =
1
n   1
n X
i=1
(xi   ¯ x)(xi   ¯ x)
T, (2.7)
the regular unbiased estimator of ⌃xx.F u r t h e r m o r e ,r e c a l l i n gt h a t⌃ hh and ⌃hx depend on B0,
we may obtain, b B,t h ep⇥K matrix with columns b  m,w h e r eb  m is obtained by maximizing
each marginal likelihood speciﬁed by (2.5), yielding b  m as the nonparametric maximum
likelihood estimate (NPMLE)(Murphy and Van der Vaart, 2000) if (2.5) is semiparametric
or as the maximum likelihood estimate (MLE) if (2.5) is parametric.
The only remaining quantity to estimate is ⌃✏✏.T oe s t i m a t e⌃ ✏✏,w ea s s u m eac o p u l a
model on the joint distribution of ✏.W e c h a r a c t e r i z e t h e j o i n t d i s t r i b u t i o n f u n c t i o n G(✏)
34through the copula
G(✏)=C⌃✏✏(G1(✏1),...,G M(✏M)),
where C⌃✏✏ is a copula parametrized by the correlation matrix ⌃✏✏.B y d e ﬁ n i t i o n ,f o r u =
(um)1mM,a n yf u n c t i o nC(u):( 0 ,1)M ! (0,1) is a copula if it is a continuous distribution
function and
lim
uj!1,j6=m
C(u)=um.
One practical example of a copula function is the Gaussian copula:
C⌃✏✏(u)=  ⌃✏✏( 
 1(u1),..., 
 1(uM)),
where  (·) is the standard normal distribution function and  ⌃✏✏(·)i st h ed i s t r i b u t i o nf u n c -
tion of the centered multivariate normal with unit variances and correlation matrix ⌃✏✏.
Recognizing that ✏m = x
T m0 +hm0(zm), we can write the distribution function for z condi-
tional on x as
F(z)=C⌃✏✏ [G1 {x
T 10 + h10(z1)},...,G M {x
T M0 + hM0(zM)}].
Now, since z is not observed, observing the vector y and missing indicator   implies that
z lies in some region, which in turn – conditional on x – implies that ✏ lies in a particular
region. For a toy example, suppose y
T =( y1,y 2,y 3)=( 3 ,5,0) and  
T =( 0 ,1,0), where y1 is
continuous and fully observed, y2 is continuous and censored, and y3 is binary. That implies
that z lies in the region {(z1,z 2,z 3)
T 2 R3 : z1 =3 ,z 2 > 5,z 3  0},w h i c hi nt u r ni m p l i e s
that ✏ lies in the region {(e1,e 2,e 3)
T 2 R3 : e1 = x
T 10 + h(1)(3),e 2 > x
T 20 + h(2)(5),e 3 
x
T 30 + h(0)}.
Then the likelihood for ⌃✏✏ can clearly be written
L(⌃✏✏;V,H0,B0)=
n Y
i=1
f(yi|xi,⌃✏✏,H0,B0)
where H0 =( hm0(·))1mM and f(yi|xi, i,⌃✏✏,H0,B0)c a nb ec o m p u t e db yi n t e g r a t i n g
the copula density c⌃✏✏ [G1 {x
T 10 + h10(z1)},...,G M {x
T M0 + hM0(zM)}]o v e rt h er e g i o n
in which zi lies.
35We then obtain
b ⌃✏✏ =a r g m a x
⌃✏✏
L(⌃✏✏;V, b H, b B)( 2 . 8 )
where b H =( b hm(·))1mM and b hm(·) is obtained as the NPMLE or MLE of hm(·)f r o mt h e
marginal model (2.5).
Final estimates of   are obtained from (2.7) and by plugging in (2.8), (2.7), and b B into
(2.6).
2.2.3 Assessing variability
In this section we examine the asymptotic distribution of our estimates b ✓.R e c a l l t h a t
b ✓ = g(b  ). Thus, taking a Taylor expansion,
n
1
2(b ✓   ✓)=n
1
2 {g(b  )   g( )}
= n
1
2 @g( )
@ 
(b      )+n
1
2Op(kb      k
2)
We show in the appendix that n
1
2(b     )c a nb ew r i t t e na sn  1
2
Pn
i=1 U i( )f o rs o m em e a n
zero functions U i( ), and thus
n
1
2(b ✓   ✓)=n
  1
2 @g( )
@ 
n X
i=1
U i( )+op(1)
which means that b ✓ is asymptotically normal. The results in the appendix along with
explicit forms of
@g( )
@  ,w h i c hc a nb ef o u n di nO g a s a w a r a( 2 0 0 7 ) ,c o u l db eu s e dt oe s t i m a t e
the distribution of b ✓. However, the variance estimates based on this asymptotic result may
be unstable and unlikely to perform well in ﬁnite samples. Thus, we employ the bootstrap
to obtain variance estimates for b ✓.
Let {b ✓
⇤
b}1bB be a collection of B bootstrapped estimates of ✓,w h e r eb ✓
⇤
b =
(b ✓⇤
bj)1jK(M+p+1) =( b a
⇤
bk, b b⇤
bk,b r⇤
bk). Then one could estimate the variability of n
1
2(b ✓   ✓)
by examining the variability of n
1
2(b ✓
⇤
b   b ✓). One can estimate the standard error of b ✓j by
computing the standard deviation of the collection of bootstrap values {b ✓⇤
bj}1bB.
To construct a (1   ↵)% conﬁdence interval for ✓j,o n ec a nc o m p u t et h es o - c a l l e dper-
centile interval as (Cl,C u), where the endpoints are the lower and upper ↵/2q u a n t i l e so f
36{b ✓⇤
bj}1bB,r e s p e c t i v e l y .B e c a u s es o m eo ft h ee s t i m a t o r sm a yb eb i a s e d ,i ti sa l s op o s s i b l et o
compute an adjusted percentile interval, by adjusting the percentile interval according to an
estimate of the bias. Let d biasb ✓j = B 1 PB
b=1 b ✓⇤
bj   b ✓j be an estimate of the bias in b ✓j.T h e n
the adjusted percentile interval for ✓j is computed as (Cl   d biasb ✓j,C u   d biasb ✓j). Finally, one
can compute a basic bootstrap interval as (Cu   b ✓j,C l   b ✓j).
2.2.4 Visualizing risk proﬁles
As described in section 2.2.2, a copula must be speciﬁed to obtain sCCA estimates. In
practice, while there may be compelling scientiﬁc motivation for the structure of the marginal
models (2.5), there will often be less clear scientiﬁc reasoning available for choice of the copula
C⌃✏✏(·), and copulas may be speciﬁed solely for computational simplicity. Thus, one might
be concerned about the dependence of sCCA estimates on a potentially misspeciﬁed copula.
To alleviate these concerns, one can examine the relationship between a risk proﬁle b
T
kx
and y nonparametrically. By smoothing, transformations of ym over the risk proﬁle b
T
kx one
can get a clearer view of how the risk proﬁle predicts values of ym irrespective of the copula
originally used.
2.3 Example
2.3.1 Genetic study to identify risk proﬁles for autoimmune dis-
ease
We apply our sCCA to a study of shared autoimmunity with the goal of identifying risk
proﬁles associated with 4 autoantibodies: anti-nuclear antibodies (ANA), anti-cyclic citrulli-
nated protein (CCP) antibodies, anti-transglutaminase (TTG) antibodies, and anti-thyroid
peroxidase antibodies (TPO). These 4 autoantibodies are respectively markers for 4 au-
toimmune diseases (ADs): systemic lupus erythematosus (SLE), rheumatoid arthritis (RA),
celiac disease and autoimmune thyroid disease. The genetic markers consists of 67 single-
nucleotide polymorphisms (SNPs) previously published as potential risk markers for these
four ADs. We use the autoantibodies in place of the disease phenotypes because, while the
co-occurrence of multiple ADs within individuals has been documented (Somers et al., 2006),
37it would be rare, even for someone who is at high risk for the spectrum of ADs, to have more
than one. In contrast, autoantibodies can be present in individuals predisposed to having the
disease even in the absence of a disease phenotype. For example, while co-occurrence of ADs
within families is well documented (Somers et al., 2006), family members of those with au-
toimmune disease may also experience elevated levels of autoantibodies if they haven’t (yet)
exhibited the disease phenotype. In this study, the autoantibodies are considered markers
for subjects at higher risk for SLE, celiac, and autoimmune thyroid disease.
The study cohort includes 1265 individuals of European ancestry with RA identiﬁed
through electronic medical records at Partners Healthcare (Liao et al., 2010; Kurreeman
et al., 2011). Due to a limit of quantiﬁcation, the antibody measurements are highly unre-
liable when the values are either very low or very high. ANA and TTG rarely reached the
lower limit of quantiﬁcation in our study cohort, with only 1 and 4 people below the limit,
respectively. On the other hand, 28% of CCP measurements were below the limit, as well
as 74% of TPO measurements. Similarly, few people were above the limit of quantiﬁcation
for ANA (42 people, 3%) and TTG (2 people), while a full 26% of CCP measurements were
above the limit. No TPO measurements were above the limit. A convenient approach to
incorporating such quantiﬁcation limitations is by assuming a marginal proportional odds
model and truncating the observations at the limit of quantiﬁcation, which corresponds to
(2.5) with ✏m coming from a logistic distribution. Finally, we used a Gaussian copula to
estimate ⌃✏✏ and quantile-based bootstrap CIs to estimate variability in b ✓.
We estimated ⌃hh to be
b ⌃hh =
0
B
B
@
1.25 0.20 0.21 0.22
0.20 1.48 0.25 0.04
0.21 0.25 1.45  0.13
0.22 0.04  0.13 1.20
1
C
C
A,
suggesting that all autoantibodies were moderately positively correlated, with the exception
of CCP and TPO, which exhibited a very small positive covariance, and TPO and TTG,
which were moderately negatively correlated. The canonical correlations were estimated to
be 0.63, 0.54, 0.39, and 0.38, with proportions of variance explained 0.091, 0.098, 0.033, and
0.033, for the ﬁrst through fourth directions, respectively. Thus, there is a clear separa-
tion between the ﬁrst two sCCA directions, which explain a much larger proportion of the
38variance, and the last two directions.
The results for the ﬁrst two sCCA directions are depicted in ﬁgure 2.1. In that ﬁgure,
we see that the primary sCCA autoantibody direction is driven primarily by a positive
association with TPO and a negative association with CCP. Contributing slightly less to the
ﬁrst direction is a positive association with ANA, while TTG contributes a small amount
in the positive direction. The second direction is driven primarily by positive association
with CCP, and secondarily by positive associations to the other three autoantibodies. Thus,
we can potentially construe the ﬁrst direction as non-CCP-related autoimmunity and the
second direction as CCP-related autoimmunity. For the ﬁrst direction, the 95% conﬁdence
intervals (CI) for ANA, CCP, and TPO all exclude 0, while for the second direction, only
CCP’s CI excludes 0. The third direction is driven primarily by a positive association with
TTG, and the fourth direction is driven primarily by a positive association with ANA and
aw e a k e rn e g a t i v ea s s o c i a t i o nt oT T G ,t h o u g ha l lC I sf o rt h e s ed i r e c t i o n si n c l u d e0 .
The risk proﬁle for non-CCP-related autoimmunity is driven primarily by rs2187668,
which had previously shown associations to SLE (Taylor et al., 2011) and celiac (van Heel
et al., 2007) and is located in the MHC region which is known to a↵ect immune function.
The 95% CI for the contribution of rs2187668 also excludes 0. Other SNPs who have CIs
that exclude 0 are rs2366293 and rs10742326, both previously associated with SLE (Graham
et al., 2011; Gateva et al., 2009). Female gender also had a CI that excluded 0.
On the other hand, the risk proﬁle for CCP-related autoimmunity is driven primarily by
rs1861525 on the CYCS gene which also had been previously linked to SLE (Gateva et al.,
2009). Other important SNPs include rs3129860 (MHC region, previously associated with
SLE (Taylor et al., 2011)), rs6457620 (previously associated with multiple sclerosis (Haﬂer
et al., 2007) and RA (Denny et al., 2010)), rs6679677 (on RSBN1, previously associated
with RA (Burton et al., 2007) and hyperthyroidism (Eriksson et al., 2012)), and rs3087243
(CTLA4 gene, previously associated with both autoimmune thyroid disease (Ueda et al.,
2003) and RA (Plenge et al., 2005)). All the CIs for the listed SNPs excluded 0.
We ﬁnally present plots of the ranks of each ym smoothed against the ﬁrst two risk
39Figure 2.1: First two canonical directions for x and y in the autoantibody study. Height
and color of points represent the contribution of each component to the canonical direction.
Black line indicates 0. Line ranges represent bootstrap estimates of 95% conﬁdence intervals.
Scale is not listed because the directions are identiﬁable only up to a scaling constant.
40Figure 2.2: Nonparametric smoothing of relative rank of autoantibody measure against risk
proﬁle. Color indicates autoantibody: ANA (green), CCP (yellow), TTG (gray), TPO(red).
The ﬁrst risk proﬁle is in the top left, the second is top right, and the third is bottom left.
proﬁles to examine the predictive value of the risk proﬁles apart from the chosen Gaussian
copula. The use of ranks makes sense because those with very high and very low values of the
autoantibodies do not have interpretable values apart from their rank. Ranks are normalized
as rank(yim)/m a x i rank(yim)s ot h a ts c a l e sa r ee q u i v a l e n ta c r o s sa l la u t o a n t i b o d i e s .I nﬁ g u r e
2.2 the smoothed plots are depicted, and we recover associations similar to those that would
be expected by examining the canonical directions. For example, we saw from ﬁgure 2.1 that
the ﬁrst canonical direction was driven primarily by a strong positive association to TTG
and a strong negative association to CCP. Figure 2.2 conﬁrms this – those with high values
of the risk proﬁle tend to have lower ranks of CCP and higher ranks of TTG. Similarly,
the second risk proﬁle shows a strong positive association with CCP and weaker positive
associations with the other three autoantibodies. Thus, we see that deriving the risk proﬁles
from the Gaussian copula gives a reasonable result that is consistent with the underlying
data.
2.3.2 Simulation results
We performed simulations to investigate the ﬁnite sample performance of sCCA. We gener-
ated data under the Gaussian copula model, where, for a given ⌃✏✏ and ⌃xx,w eg e n e r a t e d
✏ ⇠  ⌃✏✏ and x ⇠  ⌃xx and
zm = h
⇤
m(x
T m0 + ✏m).
41We used M =4o u t c o m e sa n dp =1 0p r e d i c t o r s . T h et r a n s f o r m a t i o n sw e r ec h o s e nt ob e
h⇤
1(x)=ex,h ⇤
2(x)=x3,h ⇤
3(x)=x,a n dh⇤
4(x)= exp{ ex}. To demonstrate sCCA’s ability
to handle diverse y,w et h r e s h o l d e dy2 and y3 at 0, creating binary variables:
ym =
8
> <
> :
zm,m =1 ,4
1,z m > 0,m=2 ,3
0,z m  0,m=2 ,3.
We considered sample sizes of n =1 0 0a n dn =5 0 0 ,a n dw ec o n s i d e r e dv a r i o u sc o v a r i -
ance structures for ⌃✏✏, including independence (⌃✏✏ = I), exchangeable (⌃✏✏ =0 .311
T+0.7I),
and unstructured
⌃✏✏ =
2
6 6
4
10 .16  0.12 0.49
0.15 1  0.01 0.36
 0.12  0.01 1 0.02
0.49 0.36 0.02 1
3
7 7
5.
For ease of presenting simulation results, we will refer to the unique o↵-diagonal ele-
ments of ⌃✏✏ as  ✏ =(  12,  13,  14,  23,  24,  34)
T,w h i c hf o rt h eu n s t r u c t u r e dc a s ew o u l d
be (0.15, 0.12,0.49, 0.01,0.36,0.02)
T.
Similarly, for ⌃xx,w ec o n s i d e r e dt w od i ↵ e r e n ts t r u c t u r e s :e x c h a n g e a b l e( ⌃ xx =0 .1 ⇥
(0.311
T +0 .7I)) and unstructured
⌃xx =0 .1⇥
2
6
6 6 6 6 6 6
6 6 6 6 6
6 6
4
1.00  0.06  0.13 0.09  0.18  0.42 0.51  0.08  0.02  0.01
 0.06 1.00  0.05  0.01  0.03  0.07  0.03  0.02  0.03 0.00
 0.13  0.05 1.00  0.02  0.10  0.24  0.05  0.05  0.08  0.01
0.09  0.01  0.02 1.00  0.02  0.05 0.07  0.01 0.00 0.00
 0.18  0.03  0.10  0.02 1.00  0.14  0.10  0.03  0.06  0.01
 0.42  0.07  0.24  0.05  0.14 1.00  0.25  0.07  0.13  0.02
0.51  0.03  0.05 0.07  0.10  0.25 1.00  0.05 0.00 0.00
 0.08  0.02  0.05  0.01  0.03  0.07  0.05 1.00  0.03 0.00
 0.02  0.03  0.08 0.00  0.06  0.13 0.00  0.03 1.00  0.01
 0.01 0.00  0.01 0.00  0.01  0.02 0.00 0.00  0.01 1.00
3
7
7 7 7 7 7 7
7 7 7 7 7 7
7
5
.
To demonstrate the performance of the bootstrap, we performed 1000 bootstrap samples for
each simulation setting for which ⌃xx is exchangeable.
We ﬁrst examine the bias in our estimators. In ﬁgure 2.3, we depict the absolute bias
of our estimators. For ease of presentation, we consider the median absolute deviation of
b bk and b ak: mb bk =m e d i a n
n
(|b bkj   bkj)|)1j4
o
.W es e ef r o mt h ep l o tt h a t ,a se x p e c t e d ,t h e
biases tend to be higher for smaller sample sizes and for later directions, e.g., the biases tend
42Figure 2.3: Absolute bias of sCCA estimators, represented by the height of bars. Color
denotes simulation setting, i.e. correlation structures of x and ✏.P a n e l si nt h el e f tc o l u m n
represent sample size of 100, while panels on the right represent n = 500. Results for
b ak, b bk,b rk,a n d ✏ are depicted in the ﬁrst through fourth rows, respectively. The x-axis
denotes denotes canonical direction (k)f o rb ak, b bk,a n db rk,w h i l et h ex - a x i sd e n o t e st h ee n t r y
in the vector for  ✏.M e d i a na b s o l u t eb i a si sg i v e nf o rb bk and b ak.
to be higher for direction 3 than for directions 2 and 1. The bias in the estimation of  ✏ is
small regardless of correlation structure and is nearly nonexistent when n =5 0 0 .I ng e n e r a l ,
it appears that there is more bias in estimation of ﬁrst direction parameters when ⌃xx is
unstructured rather than exchangeable.
Much of the bias depicted in 2.3 can be attenuated by adjusting each b ✓j by the estimated
bias d biasb ✓j
b ✓j,adj = b ✓j   d biasb ✓j.
Figure 2.4 depicts absolute bias for the bias-adjusted sCCA estimators b ✓j,adj and shows a
dramatic reduction in the magnitude of bias. However, the estimates of the third and fourth
canonical directions may still incur relatively large amounts of bias in practice.
We also examined the performance of the bootstrap in estimating the variability in
b ✓. In ﬁgure 2.5, we depict the performance of bootstrap standard errors, and in ﬁgure
2.6 we depict the performance of bootstrap conﬁdence intervals. For ease of presentation,
the median coverage is given for the components of b ak and b bk.W e c a n s e e t h a t s t a n d a r d
error estimates are in general quite accurate for the empirical standard errors, with most
43Figure 2.4: Adjusted absolute bias of sCCA estimators, represented by the height of bars.
Color denotes simulation setting, i.e. correlation structure of ✏ (the correlation structure of
x is exchangeable). Panels in the left column represent sample size of 100, while panels on
the right represent n =5 0 0 .R e s u l t sf o rb ak, b bk,b rk,a n db  ✏ are depicted in the ﬁrst through
fourth rows, respectively. The x-axis denotes denotes canonical direction (k)f o rb ak, b bk,a n d
b rk,w h i l et h ex - a x i sd e n o t e st h ee n t r yi nt h ev e c t o rf o r ✏.M e d i a na b s o l u t eb i a si sg i v e nf o r
b bk and b ak.
dots falling on or near the dotted line that represents perfect estimation. Importantly, for
direction 1, bootstrap estimates of the standard error, the only signiﬁcant departures from
the dotted line correspond to overestimates – for b a1 when n =1 0 0 .T h u s ,i fa n y t h i n g ,t h e
bootstrap is conservative in estimating standard errors. It seems that for later directions,
the bootstrap may at times underestimate the standard error, especially for b bk.
We use percentile conﬁdence intervals for all measures besides rk,f o rw h i c hw eu s et h e
basic interval. When n =5 0 0 ,c o n ﬁ d e n c ei n t e r v a lc o v e r a g ei sq u i t eg o o df o ra l le s t i m a t o r s
except for b a4,a n db b4,w h i c hi n d i c a t e so n c ea g a i nt h a tp e r f o r m a n c eo fs C C Ae s t i m a t e sm a y
degrade once more than a few directions are obtained. Conﬁdence interval coverage is similar
for n =1 0 0 ,w i t hd i s a p p o i n t i n gc o v e r a g ef o rb a1 and b r2.
To get a more granular picture of the performance of sCCA, we depict results in de-
tail for ⌃xx exchangeable and ⌃✏✏ unstructured. In ﬁgure 2.7 we illustrate results for the
canonical directions with n = 500. Plots depict averages of b ak and b bk across the 1000 simu-
lations. Red dots depict the average estimates, and blue dots depict average bias-corrected
estimates. Horizontal bars depict true parameter values. Black vertical bars depict the em-
44Figure 2.5: Estimated bootstrap standard errors versus empirical standard errors. Color de-
notes simulation setting, i.e. correlation structure of ✏ (the correlation of x is exchangeable).
Columns represent canonical direction, all components of  ✏ are depicted under direction 1.
Results for b ak, b bk,b rk,a n db  ✏ are depicted in the ﬁrst through fourth rows, respectively.
45Figure 2.6: Conﬁdence interval coverage for sCCA estimators. Color denotes simulation
setting, i.e. correlation structure ✏ (the correlation structure of x is exchangeable). Panels
in the left column represent sample size of 100, while panels on the right represent n =5 0 0 .
Results for b ak, b bk,b rk,a n db  ✏ are depicted in the ﬁrst through fourth rows, respectively. The
x-axis denotes denotes canonical direction (k)f o rb ak, b bk,a n db rk,w h i l et h ex - a x i sd e n o t e s
the entry in the vector for b  ✏.M e d i a nc o v e r a g ei sg i v e nf o rb ak and b bk.
46pirical 5%/95% quantiles of the estimates, which we will refer to as empirical intervals, and
blue vertical bars depict average bootstrap conﬁdence intervals.
We can see that the point estimates compare well to the true parameters for the ﬁrst two
directions. Performance of the sCCA estimates degrades as the third and fourth directions
are obtained, both in terms of bias and size of empirical intervals. However, bias-corrected
estimates remain close to the true parameter values even in the later directions.
Furthermore, we illustrate results for b ⌃✏✏ and b rk in ﬁgure 2.8. We see that the estimates
of b rk and the components of b ⌃✏✏ compare quite favorably to their true values.
At smaller sample sizes, performance degrades much faster. In ﬁgure 2.9, we see that
the ﬁrst direction is once again quite accurate, but the other three directions are much less
accurate, with similar results for b bk.E s t i m a t i o n o f ⌃ ✏✏ remains quite good at the lower
sample size, but estimation of rk is also worse after the ﬁrst direction.
2.4 Discussion
We have proposed semiparametric canonical correlation analysis, a method to relate a set of
covariates x to a diverse y.T h a ti s ,s C C Aa l l o w sr e s e a r c h e r st ob u i l dr i s kp r o ﬁ l e sf o rm a n y
related phenotypes, even when those phenotypes are on incomparable scales, measured in
completely di↵erent ways, or incompletely observed. Moreover, the canonical directions may
o↵er insight into clustering or relatedness in x and y or into subgroups within the data.
The assumption of 2.5 should not be considered restrictive, since, for a given gm in the
absence of the linear predictor  x
T m0,s o m ehm0 can always be found to satisfy the model.
However, the necessity of the parametric copula function may raise worries of misspeciﬁca-
tion. To that end, we also propose nonparametric smoothing as a way to verify the predictive
accuracy of the sCCA risk proﬁles in the event of misspeciﬁcation of the copula function.
We have demonstrated sCCA’s potential by applying it to a study to identify risk proﬁles
for autoimmune disease. We identiﬁed risk proﬁles for two potential types of autoimmune
traits – non-CCP autoimmunity and CCP-related autoimmunity – and we veriﬁed them
using the nonparametric smoothing method.
Our sCCA methods as proposed above are not suitable to high-dimensional x,s i n c e
47Figure 2.7: Average parameter estimates and empirical intervals for sCCA directions a and
b,w i t hn =5 0 0 ,⌃xx exchangeable, and ⌃✏✏ unstructured. All averages are taken over all
1000 simulations. Black dots represent average point estimates, and black lines represent
empirical 90% intervals. Horizontal lines represent true parameter values. The ﬁrst panel
represents the ﬁrst direction, the second panel represents the second direction, and so on.
48Figure 2.8: Average parameter estimates and empirical intervals for the proportion of vari-
ance explained rk and the o↵-diagonal elements of ⌃✏✏,w i t hn =5 0 0 ,⌃xx exchangeable, and
⌃✏✏ unstructured. All averages are taken over all 1000 simulations. Black dots represent
average point estimates, and black lines represent empirical 90% intervals. Horizontal lines
represent true parameter values.
49Figure 2.9: Average parameter estimates and conﬁdence intervals for sCCA directions a and
b,w i t hn =1 0 0 ,⌃xx exchangeable, and ⌃✏✏ unstructured. All averages are taken over all
1000 simulations. Black dots represent average point estimates, and black lines represent
empirical 90% intervals. Horizontal lines represent true parameter values. The ﬁrst panel
represents the ﬁrst direction, the second panel represents the second direction, and so on.
50Figure 2.10: Average parameter estimates and conﬁdence intervals for the proportion of
variance explained rk and the o↵-diagonal elements of b ⌃✏✏,w i t hn =1 0 0 ,⌃xx exchangeable,
and ⌃✏✏ unstructured. All averages are taken over all 1000 simulations. Black dots represent
average point estimates, and black lines represent empirical 90% intervals. Horizontal lines
represent true parameter values.
51the performance of the model 2.5 and standard covariance matrix estimates degrade as the
dimension of x grows close to the sample size n. However, there are many interesting clinical
situations where considering high dimensional x may be desirable, most notably in genomics
where the number of potential markers can be quite large. In these cases, one may want to
employ sparse estimators to improve sCCA, similar to what has been done in Witten and
Tibshirani (2009) or Zou et al. (2006).
2.5 Appendix
2.5.1 Expansions of b  
In this section, we show that it is possible to write n  1
2(b     )a sas u mo fi i dt e r m s ,w h i c h
ensures that all of the statistics of interest are asymptotically normal. There are three types
of components of b  ,t h o s ec o m i n gf r o mb ⌃xx,t h o s ec o m i n gf r o mb ⌃hx,a n dt h o s ec o m i n gf r o m
b ⌃hh.W ew i l lc o n s i d e rt h e me a c hi nt u r n .
The components of n
1
2(b ⌃xx   ⌃xx)c a nb ew r i t t e n
n
1
2(n   1)
 1
n X
i=1
(xij   ¯ xj)(xik   ¯ xik)   n
1
2 xxjk
= n
  1
2
n X
i=1
(xij   µj)(xik   µk)   n
1
2 xxjk   n
1
2(¯ xj   µj)(¯ xk   µk)+op(1)
= n
1
2
(
n
 1
n X
i=1
(xij   µj)(xik   µk)    xxjk
)
+ op(1)
for j,k 2{ 1,...,p} and  xxjk =( ⌃ xx)jk.
The components of n
1
2(b ⌃hx   ⌃hx)c a nb ew r i t t e n
n
1
2(b ⌃xxb B   ⌃xxB0)=n
1
2(b ⌃xxb B   ⌃xxb B)+n
1
2(⌃xxb B   ⌃xxB0)
= n
1
2
(
n
 1
n X
i=1
(xi   µ)(xi   µ)
T    xx
)
b B +⌃ xx
n
n
1
2(b B   B0)
o
= n
1
2
(
n
 1
n X
i=1
(xi   µ)(xi   µ)
T    xx
)
B0 +⌃ xx
(
n
  1
2
n X
i=1
Ui(B0)
)
+ op(1)
= n
  1
2
n X
i=1
{(xi   µ)(xi   µ)
TB0 +⌃ xxU i(B0)    xx} + op(1)
52where U i(B0)i sap ⇥ K matrix with columns U i( m0)a n dn  1
2
Pn
i=1 U i( m0)i st h e
inﬂuence function corresponding to b  m from model (2.5).
And the components of n
1
2(b ⌃hh   ⌃hh)c a nb ew r i t t e n
n
1
2(b B
Tb ⌃xxb B + b ⌃✏✏   B
T
0⌃xxB0 + b ⌃✏✏)=n
1
2(b B
Tb ⌃xxb B   B
T
0⌃xxB0)+n
1
2(b ⌃✏✏   ⌃✏✏)
The elaboration of the ﬁrst term follows a similar form as the elaboration of n
1
2(b ⌃hx  ⌃hx),
n
1
2(b B
Tb ⌃xxb B   B
T
0⌃xxB0)=n
1
2(b B
Tb ⌃xxb B   b B
T⌃xxb B)+n
1
2(b B
T⌃xxb B   b B
T⌃xxB0)+
n
1
2(b B
T⌃xxB0   B
T
0⌃xxB0)
= b B
T
 
n
  1
2
n X
i=1
{(xi   µ)(xi   µ)
TB0    xx}
!
b B
+ b B
T⌃xx
 
n
  1
2
n X
i=1
U i(B0)
!
+
 
n
  1
2
n X
i=1
U i(B0)
!T
⌃xxB0 + op(1)
= B
T
0
 
n
  1
2
n X
i=1
{(xi   µ)(xi   µ)
TB0    xx}
!
B0+
2
 
n
  1
2
n X
i=1
U i(B0)
!T
⌃xxB0 + op(1)
= n
  1
2
n X
i=1
 
B
T
0 ((xi   µ)(xi   µ)
TB0    xx)B0 +2( U i(B0))
T ⌃xxB0
 
+ op(1)
For the second term, consider the function that is solved to obtain b ⌃✏✏.L e t b  n(⌃) =
n 1 Pn
i=1  (⌃;Vi, b H(yi), b B)b et h es c o r ee q u a t i o n sb a s e do nL(⌃✏✏;V, b H, b B)u s e dt oo b t a i n
b ⌃✏✏.T h en o t a t i o nb H(yi) indicates that the value at which b hm(·) is evaluated depends on yim
(the dependence on  i is suppressed).
b  n(⌃) = n
 1
n X
i=1
 (⌃;Vi, b H(yi), b B)
= n
 1
n X
i=1
 (⌃;Vi,H0(yi),B0)+n
 1
n X
i=1
˙  (⌃;Vi,H0(yi),B0)
T(b  (yi)    0(yi))+
kb      0k
2
53where ˙  (⌃;Vi,H,B)i st h ed e r i v a t i v eo f (⌃;Vi,H,B)w i t hr e s p e c tt o  =
( jm,h m(yim))1mM,1jp,  0(yi)=(  jm0,h m0(yim))1mM,1jp,a n db  (yi)=
(b  jm,b hm(yim))1mM,1jp. Now, let V(t)=( ty,t ,tx), then
b  n(⌃) = n
 1
n X
i=1
 (⌃;Vi,H0(yi),B0)+
Z
˙  (⌃;V(t),H0(ty),B0)
T(b  (ty)    0(ty))d
(
n
 1
n X
i=1
IV(t)Vi
)
+ kb      0k
2
Because n 1 Pn
i=1 IV(t)Vi has bounded total variation we have from (Zeng and Lin, 2010)
that
b  n(⌃) = n
 1
n X
i=1
{ (⌃;Vi,H0(yi),B0)+U i( 0)} + kb      0k
2
= n
 1
n X
i=1
 
⇤
i(⌃) + kb      0k
2 =  
⇤
n(⌃) + kb      0k
2
where U i( 0) is a mean-zero function of the inﬂuence function for b  .T h i sm e a n st h a t ,t h e
components of n
1
2(b ⌃✏✏   ⌃✏✏)c a nb ew r i t t e na s
 n
  1
2
n X
i=1
˙  
⇤
n(⌃✏✏)
 1 
⇤
i(⌃✏✏)+op(1).
So, ﬁnally, the components of n
1
2(b ⌃hh   ⌃hh)c a nb ew r i t t e n
n
  1
2
n X
i=1
h
B
T
0 ((xi   µ)(xi   µ)
TB0    xx)B0 +2( U i(B0))
T ⌃xxB0   ˙  
⇤
n(⌃✏✏)
 1 
⇤
i(⌃✏✏)
i
+ op(1)
And the demonstration that n  1
2(b      )c a nb ew r i t t e na sas u mo fi i dt e r m si sc o n c l u d e d .
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553.1 Introduction
An important goal of genome-wide association studies (GWAS) is to explore susceptibility to
complex diseases. These studies have led to identiﬁcation of many genomic regions as puta-
tively harboring disease susceptibility alleles for a wide range of disorders. For patients with
a particular disease, GWAS have also been performed to identify genetic variants associated
with progression of disease. The disease progression is often monitored by longitudinally
measured biological markers. Such longitudinal measures allow researchers to more clearly
characterize clinical outcomes that cannot necessarily be captured in one or even a few mea-
surements. For example, trajectories of a measure called disease activity score (DAS) are
often used to quantify the progression of rheumatoid arthritis (RA) (Prevoo et al., 1995),
and forced expiratory volume can similarly be used to monitor the progression of lung health
(Yang et al., 2009). For HIV-infected patients, the trajectories of HIV RNA (viral load) and
CD4+ Tc e l lc o u n t sa r ei m p o r t a n tp a r a m e t e r sf o rm o n i t o r i n gt h ed i s e a s ea n dd e t e r m i n i n g
optimal treatment strategies.
The most common approach to analyzing longitudinal data of this kind is to use linear
mixed e↵ects (LME) models (Laird and Ware, 1982), which relate the longitudinal outcome
y =( y1,...,y r)
T,m e a s u r e da tt i m e st =( t1,...,t r)
T,l i n e a r l yt og e n e t i cc h a r a c t e r i s t i c sz,
covariates x,a n dt with both ﬁxed and random e↵ects. However, in general, such a lin-
ear relationship is likely to be overly simplistic, especially for markers such as DAS that
may oscillate over time. To incorporate nonlinear trajectories, nonlinear and nonparametric
mixed e↵ects models as well as functional regression methods have been proposed (Davidian
and Giltinan, 2003; Lindstrom and Bates, 1990; Rice and Wu, 2001; Wu and Zhang, 2002;
Gertheiss et al., 2013; Guo, 2002; Ramsay, 2006, e.g.). These methods typically do not
specify the functional form of the trajectories a priori but rely on nonparametric smoothing
or basis function expansions. Some of these methods also require additional assumptions
such as dense and/or regular measurement times. For example, the functional smoothing
random e↵ects model (Chiou et al., 2003) regresses a trajectory y onto z, x,a n dt,b u t
requires y to be densely and regularly observed, a restriction which is not commonly met in
the longitudinal setting. Another drawback of standard nonparametric approaches is that
56the e↵ective degrees of freedom (DF) tends to be quite large, which would in turn lead to
low power in identifying important genomic variants. To e↵ectively capture the nonlinearity
with potentially low DF, functional principal component analysis (FPCA) methods have
been proposed in recent years (Castro et al., 1986; Rice and Silverman, 1991; Yao et al.,
2005; Hall et al., 2006). FPCA methods estimate a few leading eigenfunctions that can be
used to approximate the space of the true trajectory functions with minimal assumptions on
the functional form. However, most existing FPCA methods focus primarily on estimation
and regression problems. Although some of these methods could be used to derive testing
procedures, such procedures would require performing functional regression for each of the
millions of variants in a GWAS, which would be computationally infeasible in most settings.
Furthermore, these regression methods require restrictive normality assumptions which may
lead to invalid tests when the assumptions are violated.
In this paper, employing FPCA along with a variance component testing framework,
we propose a Functional Principal Variance Component (FPVC) testing procedure that
can capture the nonlinear trajectories without requiring a normality assumption or ﬁtting
individual functional regression models. Speciﬁcally, we conceive of y as a noisy realization
of a smooth underlying function Y (·), and we employ FPCA to identify the major patterns of
variation in Y (·) by estimating its underlying eigenfunctions. We approximate Y (·)a sal i n e a r
combination of these eigenfunctions. For each patient, his/her Y (·)i st h e na p p r o x i m a t e db ya
weighted average of the estimated eigenfunctions, with weights corresponding to functional
principal component loadings or scores. Since longitudinal data tends to be sampled at
irregular time intervals, we use the best linear unbiased predictor (BLUP) to estimate the
scores. The BLUP was also the basis for FPCA with sparse longitudinal data in the principal
analysis via conditional expectation (PACE) method (Yao et al., 2005) under a normality
assumption. Here, we use BLUP to motivate our testing procedure but do not require the
normality for the validity of the FPVC test. The test statistic can be derived through the
variance component testing framework and viewed as a summary measure of the overall
covariance between the estimated subject-speciﬁc scores, which characterize the person’s
trajectory, and the genetic markers. Similar variance component tests have previously been
57proposed for standard linear and logistic regressions with observed single outcomes (Wu
et al., 2011).
The primary virtues of FPVC testing are threefold. First, we separate the procedure
into two stages of distinct complexity in order to make it feasible on the genome-wide scale.
In the ﬁrst stage, we model y ﬂexibly using FPCA and obtain a succinct summary of y for
each patient, once and for all. In the second stage, we perform a rather simple model on
the genome-wide scale. Thus, we segregate the computationally complex stage (which need
occur only once) from the genome-wide stage (which could require the same computation on
the order of millions of times). Second, the summary of y that we obtain from FPCA is the
most succinct summary possible, as the eigenfunctions identiﬁed by FPCA are the functions
that explain the most variability in y.T h i r d ,o u r t h e o r e t i c a l r e s u l t s s u g g e s t t h a t t h e n u l l
distribution of the FPVC test statistic reduces to a simple mixture of  2 distributions. The
variability due to estimating the eigenfunctions does not induce any additional noise at the
ﬁrst order under the null, which greatly simpliﬁes the estimation of the null distribution.
The structure of the rest of the paper is as follows. In section 3.2, we describe FPCA
and introduce FPVC testing and our main results. In section 3.3, we discuss simulation
results. In section 3.4, we apply our proposed method to a study to detect the e↵ects of
genetic markers on the progression of low-density lipoprotein (LDL) cholesterol. In section
3.5 we discuss further implications of our procedure.
3.2 Functional principal variance component testing
3.2.1 The test statistic
In this section, we propose a testing procedure for assessing the association between a set of
genetic markers and a longitudinally measured outcome y,a d j u s t i n gf o rc o v a r i a t e s .L e tt h e
data for analysis consist of n independent random vectors V = {Vi =( y
T
i,t
T
i,z
T
i,x
T
i)
T}
n
i=1,
where yi =( yi1,...,y iri)
T is a vector of outcome measurements taken at times ti =
(ti1,...,t iri)
T 2T ri, T is a closed and bounded interval, zi =( zi1,...,z ip)
T is a vector of
genetic markers of interest, and xi =( 1 ,x i1,...,x iq)
T is a vector of additional covariates that
are potentially related to the outcome, all measured on person i.F o re a c hi,w et a k e( z
T
i,x
T
i)
T
58to be distributed as (z
T,x
T)
T.
Our goal is to test the null hypothesis
H0 : yi ? ziS | xi (3.1)
where ziS =( zij1,...,z ijs)
T is a set of genetic factors to test, identiﬁed by the index set
S = {j1,...,j s}⇢{ 1,...,p}. Special cases include marginal testing, as in traditional GWAS,
where S = {j} for some j 2{ 1,...,p},o rg l o b a lt e s t i n gw h e r eS = {1,...,p}.
To model the longitudinal trajectory, we assume that yir is a noisy sample of a smooth
underlying function Yi(·), evaluated at the point tir,
yir = Yi(tir)+✏ir,
where, for each i, Yi(·) is distributed as Y (·)a n dE[Y (t)] = µ(t), Cov{Y (s),Y(t)} = G(s,t),
for any s,t 2T,a n d✏ir is a random error independent of Yi(·),xi,a n dzi,w i t hE[✏ir]=0 ,
and Var(✏ir)= 2.F u r t h e r m o r e ,w ea s s u m et h e r ei sa no r t h o g o n a le x p a n s i o no fG,
G(s,t)=
K X
k=1
 k k(s) k(t),
for s,t 2T,w h e r e{ k(·)}K
k=1 are the eigenfunctions associated with non-negative nonin-
creasing eigenvalues { k}K
k=1,a n dK could be inﬁnity. Then we can express the observed
data as a linear combination of the population mean µ(·)a n dt h ee i g e n f u n c t i o n s
yir = µ(tir)+
K X
k=1
⇠ik k(tir)+✏ir. (3.2)
where
⇠ik =
Z
T
{Yi(t)   µ(t)} k(t)dt
are independent random variables with E[⇠ik]=0a n dV a r ( ⇠ik)= k.T h u s , yi relates to
xi and zi only through the underlying trajectory Yi(·)w h o s er a n d o m n e s si sc a p t u r e db yt h e
random coe cients {⇠ik}K
k=1.T h u st e s t i n g( 3 . 1 )i se q u i v a l e n tt ot e s t i n g
H0 : {⇠ik}
K
k=1 ? ziS | xi
However, direct assessment of the association between {⇠ik}K
k=1 and ziS is di cult since
{⇠ik}K
k=1 are unobservable and K could be inﬁnity. To handle the high dimensionality in
59{⇠ik}K
k=1,w en o t et h a t ,d e s p i t et h ef a c tt h a tt h eu n d e r l y i n gt r a j e c t o r yYi(·)i sal i n e a rc o m -
bination of a potentially inﬁnite number of eigenfunctions, we in general need only a ﬁnite
number to account for nearly all of the variability in y. And because the eigenfunctions are
ordered so that the kth eigenfunction explains the kth most variability in y,w ec a nt h e n
approximate Yi(·)u s i n go n l yt h eﬁ r s tK eigenfunctions
Yi(t) ⇡ µ(t)+
K X
k=1
⇠ik k(t),
where K<1 could be chosen such that the ﬁrst K directions capture a proportion of the
variation at least as large as } 2 (0,1]. To replace {⇠ik}K
k=1 with observable quantities, we
propose to use the so-called BLUP
e ⇠ik =  k 
T
ik⌃
 1
yi (yi   µi)( 3 . 3 )
where  ik =(  k(ti1),...,  k(tiri)
T,µi =( µ(ti1),...,µ(tiri)
T,a n d⌃ yi =C o v ( yi,yi)s u c ht h a t
(⌃yi)rl = G(tir,t il)+ 2 rl and  rl = I{r=l}.I nt h eP A C Em e t h o do f( Y a oe ta l . ,2 0 0 5 ) ,e ⇠ik was
obtained as E[⇠ik|yi]u n d e rt h ea s s u m p t i o nt h a t⇠ik and ✏ir are jointly normal, but we don’t
require normality here. We simply take e ⇠ik as an observable and reasonable approximation
to ⇠ik even if normality does not hold, as has been argued in (Robinson, 1991; Jiang, 1998).
Thus, we propose to test (3.1) by testing
H
†
0 : {e ⇠ik}
K
k=1 ? ziS | xi.
Taking note that the association we seek to test is conditional on x,o n em a yc o n s t r u c ta
test for H0 by regressing e ⇠i =( e ⇠1,...,e ⇠K)
T onto (xi,ziS). However, this is only valid if the
e↵ect of xi on Yi(·)i sc a p t u r e df u l l yb a s e do nt h em o d e lr e l a t i n gxi and e ⇠i.T or e m o v et h e
e↵ect of xi without imposing a strong assumption on how xi a↵ects Yi(·), we center ziS as
z⇤
iS =( z⇤
ij1,...,z⇤
ijs)w h e r ef o ra n yj
z
⇤
ij = zij   µzj(xi),
with µzj(xi)=E[zj|xi].
To form the test statistic for H0,w ep r o p o s et os u m m a r i z et h eo v e r a l la s s o c i a t i o n
between Y (·)a n dzS based on the Frobenius norm of the standardized covariance between
60e ⇠i and z⇤
iS
Q0 =
         
n
  1
2
n X
i=1
e ⇠iz
⇤T
iS
         
2
F
. (3.4)
Though Q0 takes a simple form and can be motivated naturally as an estimated covariance
(and can thus be considered model-free), it can also be viewed as a variance component score
test statistic similar to those considered previously for other regression models (Commenges
and Andersen, 1995; Lin, 1997). Details on the derivation of the variance component score
test statistic are given in section 3.2.2.
Both e ⇠i and z⇤
iS involve various nuisance parameters that remain to be estimated. First,
under mild regularity conditions which we outline in section 3.6, we can use FPCA to estimate
µ(·),  k,  k(·),G(·,·), and  2 by b µ(·),b  k, b  k(·), b G(·,·), and b  2,r e s p e c t i v e l y ,v i al o c a ll i n e a r
smoothing as in (Hall et al., 2006; Yao et al., 2005). Subsequently, we can estimate e ⇠ik by
b ⇠ik = b  kb  
T
ikb ⌃
 1
yi (yi   b µi)( 3 . 5 )
for b  ik =( b  k(ti1),...,b  k(tiri)
T, b µi =( b µ(ti1),...,b µ(tiri)
T, and
⇣
b ⌃yi
⌘
rl
= b G(tir,t il)+b  2 rl.T o
estimate µzj(xi), various approaches can be taken depending on the nature of x. For example,
when x is discrete, µzj(xi) can be estimated empirically. With continuous x,w em a yi m p o s e
a parametric model with
µzj(x)=gj(✓j,x)( 3 . 6 )
and obtain ¯ zj(x)a sgj(b ✓j,x), where b ✓j is an estimate of a ﬁnite-dimensional parameter ✓j.
Finally, based on {b ⇠ik}K
k=1 and ¯ zj(xi), our proposed test statistic is
Q =
1
n
X
j2S
K X
k=1
 
n X
i=1
b ⇠ikb z
⇤
ij
!2
=
 
       
n
  1
2
n X
i=1
b ⇠ib z
⇤T
iS
 
       
2
F
. (3.7)
where b z⇤
iS =( b z⇤
ij1,...,b z⇤
ijs)
T and b z⇤
ij = zij   ¯ zj(xi).
613.2.2 Connection to mixed e↵ects models
In this section, we demonstrate that the quantity (3.4) can be arrived at from a more familiar
mixed e↵ects model. Consider the model
yir = µ(tir)+
K X
k=1
⇠ik k(tir)+✏ir, (3.8)
⇠i =( ⇠i1,...,⇠ iK)
T ⇠ N(Bz
⇤
iS,⇤),✏ ir ⇠ N(0, 
2)( 3 . 9 )
where B is a K⇥s matrix with (k,j)th entry  kj and ⇤ = diag( 1,...,  K). We can obtain Q0
as the variance component score test statistic for H0 : B =0 .S p e c i ﬁ c a l l y ,l e t kj = ⌘⌫kj and
we consider a working model such that {⌫kj} are independently distributed with E(⌫kj)=0
and Var(⌫kj)= 2
k. Under this working model, H0 : B =0i se q u i v a l e n tt o
H0 : ⌘ =0 .
To obtain the variance component test statistic, rewrite the model as
yµi =
K X
k=1
 
X
j2S
⌘⌫kjz
⇤
ij + eik
!
 ik + ✏i
for centered outcome yµi =( yi1   µ(ti1),...,y iri   µ(tiri))
T,e r r o rv e c t o r✏i =( ✏i1,...,✏ iri)
T,
and random e↵ects ei =( ei1,...,e iK)
T ⇠ N(0,⇤). Then
yµi|⌫,{z
⇤
iS}
n
i=1 ⇠ N
 
X
j2S
K X
k=1
⌘⌫kjz
⇤
ij ik,⌃yi
!
where ⌃yi =
PK
k=1  k ik 
T
ik +  2Iri and Iri is the ri ⇥ ri identity matrix.
The likelihood for yµi can then be written as
L(⌘)=e x p
"
n X
i=1
⇢
 
1
2
log|⌃yi| 
1
2
 
yµi   ⌘
X
j2S
K X
k=1
⌫kjz
⇤
ij ik
!T
⌃
 1
yi
 
yµi   ⌘
X
j2S
K X
k=1
⌫kjz
⇤
ij ik
!)#
.
Because the target of inference is ⌘,w em a r g i n a l i z eo v e rt h en u i s a n c ep a r a m e t e r⌫ con-
ditional on the observed data to obtain L⇤(⌘)=E[L(⌘)|V]w h e r et h ee x p e c t a t i o ni s
62taken over the distribution of ⌫. We follow the argument in Commenges and Ander-
sen (1995) and note that the score at the null value is 0: lim⌘!0 @ logL⇤(⌘)/@⌘ =
E
hPn
i=1 y
T
µi⌃ 1
yi
P
j2S
PK
k=1 ⌫kjz⇤
ij ik | V
i
=0 . S ow ei n s t e a dc o n s i d e rt h es c o r ew i t hr e -
spect to ⌘2,lim⌘!0 @ logL⇤(⌘)/@(⌘2), and we show in section 3.6.3 that it can be written
as
E
"
@ logL(⌘)
@⌘
     
 
⌘=0
| V
#2
+ E
"
@2 logL(⌘)
@⌘2
     
 
⌘=0
| V
#
= E
"
n X
i=1
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T
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 1
yi
X
j2S
K X
k=1
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⇤
ij ik | V
#2
 
E
"
n X
i=1
X
j,j02S
K X
k,k0=1
⌫kjz
⇤
ij 
T
ik⌃
 1
yi ⌫k0j0z
⇤
ij0 ik0 | V
#
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j2S
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k=1
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n X
i=1
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 1
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⇤
ij ik
!
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 
E
"
X
j2S
K X
k=1
⌫
2
kj
(
n X
i=1
(z
⇤
ij)
2 
T
ik⌃
 1
yi  ik
)
| V
#
=
X
j2S
K X
k=1
 
n X
i=1
y
T
µi⌃
 1
yi  ik kz
⇤
ij
!2
 
X
j2S
K X
k=1
(
n X
i=1
( kz
⇤
ij)
2 
T
ik⌃
 1
yi  ik
)
up to a scaling constant.
To ﬁnally obtain Q0,w es t a n d a r d i z eb yn 1 and drop the second term because it con-
verges to a constant, yielding the score statistic
n
 1 X
j2S
K X
k=1
 
n X
i=1
y
T
µi⌃
 1
yi  ik kz
⇤
ij
!2
= n
 1 X
j2S
K X
k=1
 
n X
i=1
e ⇠ikz
⇤
ij
!2
= Q0.
taking note of the form of e ⇠ik from (3.3). Thus, our proposed test statistic can be obtained
as a variance component test under a normal mixed model framework. On the other hand,
we can also view Q0 as a simple summary of the overall covariance between the FPCA scores
63and the genetic markers. We next derive the null distribution of the FPVC test statistic
without requiring the normal mixed model to hold.
3.2.3 Estimating the null distribution of the test statistic
In order to obtain p-values for FPVC testing, we must identify the null distribution of Q.
To this end, we show in section 3.6.2 that the key quantity in Q
qkj = n
  1
2
n X
i=1
b ⇠ikb z
⇤
ij
is asymptotically equivalent to
e qkj = n
  1
2
n X
i=1
e ⇠ikb z
⇤
ij
under H0,i . e . qkj   e qkj = op(1) for each j and k.T h e k e y i d e a f o r d e r i v i n g t h e n u l l
distribution of qkj is that, since b z⇤
ij is approximately mean 0 conditional on xi,t h ev a r i a b i l i t y
due to approximating e ⇠ik by b ⇠ik does not contribute any additional noise to qkj (compared
to e qkj)a tt h eﬁ r s to r d e ru n d e rH0. Thus, we can obtain the limiting distribution of Q by
analyzing the quantity e Q =
P
j2S
PK
k=1 e q2
kj.
To characterize the null distribution of e Q,w en e e dt oa c c o u n tf o rt h ev a r i a b i l i t yi nt h e
estimated model parameters for µzj(xi)=gj(✓j,xi)i nb z⇤
ij. Without loss of generality, we
assume that for each j
n
1
2(b ✓j   ✓j)=n
  1
2
n X
i=1
Uj(xi)z
⇤
ij + op(1), (3.10)
where U(·)i ss o m e( q +1 ) - d i m e n s i o n a lf u n c t i o no fxi with E|U(xi)| < 1.I tf o l l o w st h a t
qkj = e qkj + op(1) = n
  1
2
n X
i=1
Qikj + op(1) (3.11)
where Qikj =
n
e ⇠ik   AkjU(xi)
o
z⇤
ij, Akj = E[e ⇠ik ˙ gj(✓j,xi)
T], and ˙ gj(✓j,xi)=@gj(✓j,xi)/@✓j.
We show in the appendix that the limiting null distribution of Q is a mixture of  2
1 random
variables, Q ⇠
PsK
l=1 al 2
1,w i t hm i x i n gc o e   c i e n t sd e t e r m i n e db yt h ee i g e n v a l u e so ft h ev a r i -
ance covariance matrix of {Qikj}j2S,1kK. So ﬁnally we obtain a p-value for the association
between the set zS and Y (·)a sP(
PsK
l=1b al 2
1 >Q| V), where b al is an empirical estimate of
al.
64By a similar argument, one could construct an asymptotically equivalent test statistic
by estimating e ⇠i in two stages. Instead of obtaining an estimator directly from FPCA via
equation (3.5), FPCA can be used to estimate only µ(·)a n d{ k(·)}K
k=1.B y p l u g g i n g t h e
estimated b µ(·)a n d{b  k(·)}K
k=1 into the mixed model (3.8), one can obtain what we will call
the re-ﬁtted test statistic
¯ Q = n
 1 X
j2S
K X
k=1
"
n X
i=1
¯ ⇠ikb z
⇤
ij
#2
(3.12)
where ¯ ⇠i =(¯ ⇠i1,...,¯ ⇠iK)
T is the BLUP from the model yir b µ(tir)=
PK
k=1 ⇠ikb  k(tir)+✏ir with
Cov(⇠i)=D,f o rs o m eu n s p e c i ﬁ e dp o s i t i v ed e ﬁ n i t em a t r i xD.B yt h es a m ea r g u m e n ta b o v e ,
estimation of e ⇠ik by ¯ ⇠ik contributes no additional variability to the test statistic at the ﬁrst
order. It follows that
q
†
kj = n
  1
2
n X
i=1
¯ ⇠ikb z
⇤
ij = e qkj + op(1).
and hence ¯ Q has the same limiting null distribution as Q. Not surprisingly, simulation results
suggest that the performance of ¯ Q is quite similar to the performance of Q.T h i se q u i v a l e n c e
indicates that e↵ectively our proposed testing procedure uses FPCA to estimate potentially
nonlinear bases and assesses the e↵ect of genetic markers by ﬁtting a mixed model with
these basis functions. On the other hand, the test statistics can also be viewed as a simple
summary of covariances, and – since we estimate the null distribution without relying on the
normality assumption required by the mixed models – our testing procedure remains valid
regardless of the adequacy of the mixed model.
3.2.4 Combining multiple sources of outcome information
For settings where disease progression can be better characterized by trajectories of multiple
markers, it would be desirable to test the overall association between the genetic factors and
all available markers. For example HIV progression is often characterized by both CD4+ cell
count and viral load (among other measures) over time. FPVC testing can be easily adapted
to perform a test for the overall association between zS and all outcomes of interest. To use
information in multiple outcomes, {y(m)}M
m=1, we simply perform FPCA separately on each
y(m) and obtain FPCA scores for each person and each outcome. Subject i’s scores for y
(m)
i
65would be b ⇠
(m)
i =( b ⇠
(m)
i1 ,...,b ⇠
(m)
iKm)
T,a si n( 3 . 5 ) ,a n dt h ef u l ls e to fs c o r e sf o rp e r s o ni would be
b ⇠i =( b ⇠
(1)T
i ,...,b ⇠
(m)T
i )
T.T h e nw es i m p l yp r o c e e db yt e s t i n g
H0 : {y
(m)}
M
m=1 ? zS | x
as before based on
Q = kn
  1
2
n X
i=1
b ⇠ib z
⇤T
iSk
2
F =
M X
m=1
kn
  1
2
n X
i=1
b ⇠
(m)
i b z
⇤T
iSk
2
F. (3.13)
Since each outcome may be measured on a di↵erent scale, one may use scaling or weighting
to allow scores from each outcome to contribute similarly to the test statistic. See section
3.5 for further discussion of scaling/weighting.
3.3 Simulation results
We have performed simulation studies to assess the ﬁnite sample performance of our pro-
posed testing procedure and compare its power to the standard linear-mixed-model-based
procedures. For simplicity, we focused on a single marker z in the absence of covariates and
two potential functional outcomes generated from
y
(m)
ir = Y
(m)
i (tir)+✏
(m)
ir
=s i n ( tir)+(  1)
m 1  {sin(tir/3) + cos(tir)}+
(1    )
n
bi0 +0 .5b
(m)
i1 cos(tir/4)
o
+
 zi {↵(cos(tir)+c o s ( tir/10)   sin(3tir)) +
(1   ↵)tir/7} + ✏
(m)
ir ,m =1 ,2,
where b
(m)
ij ⇠ N(0,0.25),j =0 ,1a r ei n d e p e n d e n ta n di d e n t i c a l l yd i s t r i b u t e d( i i d )r a n d o m
e↵ects and ✏
(m)
ir ⇠ N(0,0.25) are iid errors, for m =1 ,2. For each subject i,w eg e n e r a t et h e
number of observations from a Poisson distribution ri ⇠ Poisson(6) + 2, and we generate
tir uniformly over the time interval (0,2⇡). The parameter   controls the magnitude of the
genetic e↵ect. The parameter ↵ controls how linear the genetic a↵ect is – when ↵ =0t h e
genetic e↵ect is entirely linear, and when ↵ = 1 the e↵ect is entirely nonlinear. On the
66other hand,   controls the complexity of the mean process and the amount of inter-subject
variability – when   =0 ,t h em e a np r o c e s si sr e l a t i v e l ys i m p l eb u tt h ei n t e r - s u b j e c tv a r i a b i l i t y
is high, and when   =1t h em e a np r o c e s si sc o m p l e xa n dt h ei n t e r - s u b j e c tv a r i a b i l i t yi sl o w .
The genetic factor zi is generated according to a binomial(2, MAF), with MAF the minor
allele frequency.
We examined the performance of the FPVC test statistic Q (deﬁned in (3.13), here de-
noted by “FPCA”) and its asymptotically equivalent counterpart ¯ Q (deﬁned in the context of
a single outcome in (3.12), here denoted ”Re-ﬁtted”). For the purposes of comparison, we also
examined the performance of a similar test statistic that does not use FPVC but instead em-
ploys a pre-speciﬁed basis. Consider the test statistic Qlin = 1
n
P2
m=1
P2
k=1
hPn
i=1 ⇠
(m)†
ik b z⇤
i
i2
,
where ⇠
(m)†
ik is the BLUP from the linear mixed model yir =  0 +  1tir + ⇠i1 + ⇠i2tir + ✏ir.I n
the following, we denote results for Qlin by ”Linear”.
The number of FPCA scores for the mth outcome, Km,w a ss e l e c t e da st h es m a l l -
est K such that the fraction of variation explained (FVE),
PK
k=1 b  k/(
P
k b  k), was at least
} =0 .99. In the following we report power as the proportion of 1000 simulations for
which the testing procedure produced a p-value below 0.05. To ensure that the scores
for each outcome contributed comparably to the test statistics, we centered and scaled
each outcome as y
⇤(m)
ir =( y
(m)
ir   ¯ y(m))/b  
(m)
y ,p r i o rt oo b t a i n i n gb ⇠
(m)
ik and ⇠
(m)†
ik ,w h e r e
b  
(m)
y =
q
(n   1) 1 P
i,r(y
(m)
ir   ¯ y(m))2 and ¯ y(m) = n 1 P
i,r y
(m)
ir .
To demonstrate the role of sample size and MAF, we simulated data at sample sizes
n =2 0 0 ,400, and 600, and at MAFs 0.1, 0.2, and 0.3. Figure 3.1 displays results for   =0
and ↵ =1 .T h eﬁ g u r ei n d i c a t e st h a tt h ep e r f o r m a n c e so fQ and ¯ Q was similar and uniformly
dominated the performance of Qlin at any sample size and MAF. Each test maintained its
nominal size, with empirical type I error rates for Q and ¯ Q ranging between 0.034 (MAF =
0.2, n = 400) and 0.057 (MAF = 0.2 and n =6 0 0f o rQ and MAF = 0.1 and n =4 0 0f o r ¯ Q)
and for Qlin between 0.036 (MAF = 0.2 and n = 400) and 0.055 (MAF = 0.1 and n =6 0 0 ) .
By varying ↵,w ei n v e s t i g a t e dt h ep e r f o r m a n c eo fe a c hm e t h o df o rv a r i o u sl e v e l so f
linearity in the genetic e↵ect over time. Figure 3.2 displays results for n = 200, MAF = 0.1,
  =1 ,a n dv a r y i n g↵.T h e ﬁ g u r e d e m o n s t r a t e s t h a t , d e s p i t e t h e f a c t t h a t t h e t r u e e ↵ e c t
67Figure 3.1: Power to detect   using Q (FPCA), ¯ Q (Re-ﬁtted), and Qlin (Linear), with simple
mean process and high inter-subject variability (  =0 )a n dl i n e a rg e n e t i ce ↵ e c t( ↵ =1 ) .
68Figure 3.2: Power to detect   using Q (FPCA), ¯ Q (Re-ﬁtted), and Qlin (Linear), with
complex mean process and low inter-subject variability (  =1 ) ,s a m p l es i z en =2 0 0 ,a n d
MAF = 0.1. Panels correspond to varying linearity of genetic e↵ect (varying levels of ↵).
was linear when ↵ = 0, the advantage in terms of power of using FPVC did not diminish as
↵ decreased from 1 to 0. Again, the empirical type I error rates hovered around the desired
value of 0.05: ranging from 0.041 (↵ =0 . 7 5 )t o0 . 0 5 7( ↵ =0 . 2 5 )f o rQ;f r o m0 . 0 3 7( ↵ =
0.75) to 0.048 (↵ =0 )f o r ¯ Q;a n df r o m0 . 0 4 6( ↵ =0 . 7 5 )t o0 . 0 6 5( ↵ =0 . 2 5 )f o rQlin.
Similarly, as we varied  , we saw power gains by using the FPVC-based Q and ¯ Q,w i t h
the gains increasing as   approached 1, the functional form of Y
(m)
i (·)b e c a m em o r ec o m p l e x ,
and the need to ﬂexibly model it increased. Figure 3.3 demonstrates this for n = 200, MAF
=0 . 1 ,↵ =1 ,a n dv a r y i n g . The empirical type I error rates ranged from 0.040 (  =0 . 2 5 )
to 0.048 (  =0 )f o rQ;f r o m0 . 0 3 6(   =1 )t o0 . 0 4 7(   =0 )f o r ¯ Q;a n df r o m0 . 0 4 0(   =0 . 7 5 )
to 0.059 (  =1 )f o rQlin.
In all of our simulations, the FPVC methods dominated the linear method in terms
of power while maintaining desirable type I error rates. We wanted to ensure that the
improvement we were seeing was not simply due to the fact that the linear model used only
two scores, a random intercept ⇠
(m)†
i1 and a random slope ⇠
(m)†
i2 ,f o re a c ho u t c o m ew h e r e a st h e
FPVC-based methods used Km scores, where Km was often selected larger than 2. Thus, we
also considered the performance of the FPVC tests when the number of scores was ﬁxed at
2, 3, and 4, and we compared to similar tests based on pre-speciﬁed bases with the number
of scores ﬁxed at the same respective number.
69Figure 3.3: Power to detect   using Q (FPCA), ¯ Q (Re-ﬁtted), and Qlin (Linear), with linear
genetic e↵ect ↵ =1 ,n = 200, and MAF = 0.1. Panels correspond to varying levels of
complexity in the mean structure and varying levels of inter-subject variability (varying
levels of  ).
Speciﬁcally, we compared the FPVC test statistics Q and ¯ Q with Km =2t oQlin;w e
compared the FPVC test statistics with Km =3t oQquad = 1
n
P2
m=1
P3
k=1
hPn
i=1 ⇠
(m)†
ik b z⇤
i
i2
,
where ⇠
(m)†
ik is the BLUP from the mixed model yir =  0 +  1tir +  2t2
ir + ⇠i1 + ⇠i2tir +
⇠i3t2
ir + ✏ir; and we compared the FPVC test statistics with Km =4t oQcube =
1
n
P2
m=1
P4
k=1
hPn
i=1 ⇠
(m)†
ik b z⇤
i
i2
,w h e r e⇠
(m)†
ik is the BLUP from the mixed model yir =
 0 +  1tir +  2t2
ir +  3t3
ir + ⇠i1 + ⇠i2tir + ⇠i3t2
ir + ⇠i4t3
ir + ✏ir.
We found that there were some situations when using the pre-speciﬁed polynomial basis
could outperform the FPVC tests, particularly when   was near 0 and ↵ was near 1. Even in
the cases when it was possible to outperform the FPVC-based methods with a pre-speciﬁed
basis, though, one would have to know the correct number of scores to use a priori.F o r
example, as in ﬁgure 3.4, when all methods used 2 scores, the FPVC-based methods saw
large increases in power over the pre-speciﬁed model (empirical type I error rates: 0.049 for
Q and ¯ Q,0 . 0 5 2f o rQlin), and when all methods used 4 scores the FPVC-based methods
performed slightly better (empirical type I error rates: 0.050 for Q,0 . 0 4 7f o r ¯ Q,0 . 0 4 9f o r
Qcube). However, when all methods used 3 scores, the pre-speciﬁed model saw a large increase
in power over the FPVC-based methods (empirical type I error rates: 0.050 for Q and ¯ Q,
0.058 for Qquad). This suggests that, in practice, if the correct basis were known or known
approximately, then a pre-speciﬁed basis may be able to obtain higher power. However,
70Figure 3.4: Power to detect   using Q (FPCA), ¯ Q (Re-ﬁtted), and pre-speciﬁed basis test
statistics Qlin,Q quad,Q cube (Pre-speciﬁed), with mostly nonlinear genetic e↵ect (↵ =0 .75),
and low complexity mean process and high inter-subject variability (  =0 .25), sample size
n = 200, and MAF = 0.1. Panels indicate how many scores were used in testing.
over- or under-speciﬁcation of the model may result in decreased performance. With FPVC
testing, on the other hand, the number of scores chosen does not have a dramatic e↵ect
on performance. Thus, using FPVC alleviates the need to know precisely how many basis
functions to use.
Furthermore, there were many simulation settings where the pre-speciﬁed model never
approached the FPVC tests. Consider when ↵ =0a n d  =0 .75, as in ﬁgure 3.5. There,
even if you increased the number of scores used to 4, the FPVC-based methods were much
more powerful than those using a pre-speciﬁed basis.
3.4 Association between genetics and trajectory of
LDL
We applied our method to a study of the association between longitudinal LDL cholesterol
and a set of candidate single-nucleotide polymporphisms (SNPs). The study cohort consisted
of 2840 RA cases and controls identiﬁed via electronic health records (EHR) (Liao et al.,
2010). LDL measurements were also obtained via EHR. A total of 26 candidate SNPs
were identiﬁed as potentially associated with LDL. Here we are interested in assessing the
71Figure 3.5: Power to detect   using Q (FPCA), ¯ Q (Re-ﬁtted), and pre-speciﬁed basis test
statistics Qlin,Q quad,Q cube (Pre-speciﬁed), with linear genetic e↵ect (↵ =0 ) ,h i g hc o m p l e x i t y
mean process and low inter-subject variability (  =0 .75), sample size n =2 0 0 ,a n dM A F=
0.1. Panels indicate how many scores were used in testing.
association between these risk alleles and the trajectory of LDL over time.
FPCA was performed on all 2840 individuals with any LDL observations, but testing
was performed on only those 1901 with genetic information. Patients contributed between
1a n d9 3L D Lm e a s u r e m e n t s ,w i t ht h em e d i a nb e i n g1 9 ,a n da p p r o x i m a t e l y9 0 %o fp a t i e n t s
contributed between 4 and 50 LDL observations over time. Patients with only 1 measure-
ment contributed to the estimation of the mean function µ(·)b u tn o tt ot h ee s t i m a t i o no f
the eigenfunctions. The estimated mean function and eigenfunctions for LDL are depicted in
ﬁgure 3.6. The eigenfunctions roughly approximate a polynomial basis, with the ﬁrst eigen-
function approximately constant, the second approximately linear, the third approximately
quadratic, and the fourth approximately cubic.
Because the sampling mechanism of the study cohort depended on RA status, we an-
alyzed the association between LDL and the SNPs separately in RA cases and controls.
We combined the resulting p-values for cases and controls using Fisher’s method. We ﬁrst
performed a global test of any association between the entire SNP set (z1,...,z 26)
T and the
trajectory of LDL, yielding a p-value of 0.21 in cases and 0.17 in controls, for an overall p-
value of 0.15. Thus, there was not signiﬁcant evidence of any association. We next proceeded
72(a) Mean (b) Eigenfunction
Figure 3.6: FPCA results. Estimated (a) population mean and (b) eigenfunctions. In plot
(b), color denotes eigenfunction.
with exploratory analysis of the individual SNPs.
The results for marginal testing of all SNPs are depicted in ﬁgure 3.7. Five SNPs ob-
tained p-values below 0.10, and two of those were below 0.05. The lowest p-value (p =0 . 0 3 2 )
belonged to rs2081687 near the CYP7A1 gene, which had previously been associated with
non-longitudinal LDL in a population of European ancestry and replicated in a population
of African Americans (Adeyemo et al., 2012). The other SNP with a p-value below 0.05 was
rs1564348 (p =0 . 0 4 6 )w h i c hi sn e a rt h eg e n eL P Aa n dh a dp r e v i o u s l ye x h i b i t e da na s s o c i -
ation with decreased levels of non-longitudinal apolipoprotein(a) and LDL (Holmes et al.,
2011).
In order to better visualize the di↵erences FPVC testing was picking up on, we plot the
mean estimated trajectories of LDL among those with 0, 1, and 2 minor alleles, respectively,
in ﬁgure 3.8 for the SNP rs2081687. We obtained the mean estimated trajectories by aver-
aging the scores b ⇠ik across all individuals with the same number of minor alleles. In both
cases and controls, those with 0 minor alleles have the uniformly lowest estimated trajectory,
and those with 2 minor alleles have the uniformly highest estimated trajectory. In RA cases,
those with 1 and 2 minor alleles have relatively similar trajectories, while in controls all three
curves show quite a bit of separation. In both cases and controls, separation between the
73Figure 3.7: P-values of association between longitudinal LDL and 26 candidate SNPs. Col-
ored bars represent p-values of overall association, combining information from cases and
controls. Gray bars indicate component p-values computed either only in cases or only in
controls. P-values are given on the -log10 scale. For overall p-values, color denotes p<0.05
(blue), p<0.10 (teal), p>0.10 (dark green). For component p-values, color denotes whether
it was obtained from cases (dark gray) or controls (light gray).
74Figure 3.8: Estimated mean trajectories among patients with a given number of minor alleles
at rs2081687. Color and line type denote number of minor alleles. Cases are depicted in the
left panel, and controls are depicted in the right panel.
curves seems to be largest at the earliest time points.
3.5 Discussion
We have proposed functional principal variance component testing, a FPCA-based testing
procedure for assessing the association between a set of genetic variants zS and a com-
plexly varying longitudinal outcome y that is feasible on the genome-wide scale, allowing
adjustment for other covariates. Unlike the standard mixed-model-based approaches, we do
not model the trajectories {Yi(·)}n
i=1 parametrically but use the data to identify the most
parsimonious summaries of the trajectory patterns via FPCA. We subsequently test the as-
sociation between the random coe cients ⇠i and the markers of interest using a test statistic
motivated by variance component testing. Our procedure could potentially be much more
powerful than procedures based on pre-speciﬁed bases, which might su↵er power loss due to
either high degrees of freedom or inability to capture the complexity in the trajectories. Fur-
thermore, our FPVC testing is computationally e cient as we are able to perform thousands
or even millions of tests quickly by separating the time-intensive FPCA from the testing.
This makes our method feasible on the genome-wide scale where millions of marginal tests
may be necessary.
It is important to note that while we make mild assumptions on the longitudinal outcome
75y to obtain the form of our proposed test statistic, the validity of FPVC testing requires no
assumption about the relationship between y and zS. FPVC testing remains valid even if the
working mixed model (3.8) fails to hold. Additionally, while one can motivate the quantity
e ⇠ik as the conditional expectation of ⇠ik under a normality assumption on ⇠ik and ✏ir,e v e n
when this normality fails to hold, testing based on Q remains valid since the estimated
eigenvalues and eigenfunctions from functional PCA are uniformly convergent to their limits
(Hall et al., 2006). In fact, one can consider FPVC model-free in that the test statistic Q
could be motivated simply as an estimated covariance. Furthermore, we assume that the
errors ✏ir are iid with mean 0 and variance  2,b u ts o m er e l a x a t i o no ft h i sa s s u m p t i o ni s
possible for some ”degree of weak dependence and in cases of non-identical distribution”
(Hall et al., 2006), while still maintaining the validity of our procedure.
FPVC testing can also simultaneously consider multiple sources of outcome information
to better characterize complex phenotypes. With multiple longitudinal outcomes, one might
wish to ensure that scores for all outcomes are roughly on the same scale, so that each
outcome contributes comparably to the test statistic. To this end, one may consider a
weighted version of (3.13) as
Q =
M X
m=1
!mkn
  1
2
n X
i=1
b ⇠ib z
⇤
iSk
2
F,
where !m are nonnegative outcome-speciﬁc weights that can be pre-speciﬁed or data adap-
tive. Alternatively, in the absence of relevant weights, one can simply scale each y(m) so
that the magnitude of b ⇠
(m)
i is comparable across di↵erent values of m.L e ty
⇤(m)
ir = y
(m)
ir /b  
(m)
y
where b  
(m)
y =
q
(n   1) 1 P
i,r(y
(m)
ir   ¯ y(m))2 and ¯ y(m) = n 1 P
i,r y
(m)
ir .T h e n o b t a i n b ⇠
⇤(m)
i
via FPCA on {y
⇤(m)
i }n
i=1 and construct the test statistic
PM
m=1 kn  1
2
Pn
i=1b ⇠
⇤(m)
i b z⇤
iSk2
F.S u c h
as t r a t e g ya p p e a r st ow o r kw e l li ns i m u l a t i o ns t u d i e s .
3.6 Appendix
3.6.1 FPCA Assumptions
The primary result regarding FPCA we require is that the estimated scores b ⇠ik converge in
probability to the BLUP, b ⇠ik  ! p e ⇠ik.
76We reproduce here the assumptions from Hall et al. (2006) for this result, with minor
modiﬁcation.
A.1 There is an integer i0 > 1f o rw h i c ht h e r ea r en ot i e sa m o n gt h ei0+1largesteigenvalues
of G(·,·).
A.2 For the data pairs (tir,y ir)1rri;1in, ri   2a n dRn =m a x in ri is bounded by
R<1 as n !1 .
A.3 The time points tir have common density ft,w h i c hi sb o u n d e da w a yf r o m0o nT ,a n d
are independent of zi and xi.
There are further requirements in Hall et al. (2006) that pertain speciﬁcally to smooth-
ing. For example, in the local linear smoother used there, they require assumptions about
the second derivatives of the smooth functions Yi(·)i na d d i t i o nt oa s s u m p t i o n sa b o u tt h e
kernel and bandwidth used for smoothing. Since the mechanics of FPCA are not the focus
of this paper, we do not reproduce these conditions here.
To facilitate subsequent proofs, we construct the R-dimensional vectors t⇤
i =
(t⇤
i1,...,t ⇤
iR)
T and y⇤
i =( y⇤
i1,...,y⇤
iR)
T.D e ﬁ n e  i =(  i1,...,  iR)
T to be a non-missingness
indicator so that {tir,1  r  ri} = {t⇤
ir :  r =1 ,1  r  R}, {yir,1  r  ri} = {y⇤
ir :  r =
1,1  r  R},a n d ir =0f o ra l lr such that (t⇤
ir,y⇤
ir)i sn o to b s e r v e d . W eﬁ n a l l yr e q u i r e
that
A.4 For each 1  r  R, Drn =
Pn
i=1  ir !1as n !1 .
3.6.2 Justiﬁcation for the asymptotic null distribution
In this section, we establish the limiting null distribution of Q. First, note the form of Q
and e Q:
Q = q
Tq, e Q = e q
Te qq =( qkj)j2S,1kK,e q =( e qkj)j2S,1kK.
77We show that qkj   e qkj = op(1), which ensures that Q and e Q are asymptotically equivalent.
Deﬁne  kj = qkj   e qkj = n  1
2
Pn
i=1(b ⇠ik   e ⇠ik)b z⇤
ij and furthermore that
e ⇠ik =  k k(ti)
T⌃(ti)
 1 {yi   µ(ti)} and
b ⇠ik = b  kb  k(ti)
Tb ⌃(ti)
 1 {yi   b µ(ti)}
for  k(ti)=(  k(ti1),...,  k(tiri))
T,µ(ti)=( µ(ti1),...,µ(tiri))
T,a n d( ⌃ ( ti))r,l = G(tir,t il)+
 2 rl,w i t hb  (ti), b µ(ti), and b ⌃(ti) being deﬁned analogously. Then
b ⇠ik   e ⇠ik = b  kb  k(ti)
Tb ⌃(ti)
 1 {yi   b µ(ti)} 
 k k(ti)
T⌃(ti)
 1 {yi   µ(ti)}
=
n
b  kb  k(ti)
Tb ⌃(ti)
 1    k k(ti)
T⌃(ti)
 1
o
yi+
 k k(ti)
T⌃(ti)
 1µ(ti)   b  kb  k(ti)
Tb ⌃(ti)
 1b µ(ti)
=
Z
T
n
b  kb  k(⌧)
Tb ⌃(⌧)
 1 
 k k(⌧)
T⌃(⌧)
 1 
d{yiIti⌧}+
Z
T
 
 k k(⌧)
T⌃(⌧)
 1µ(⌧) 
b  kb  k(⌧)
Tb ⌃(⌧)
 1b µ(⌧)
o
dIti⌧
Then,  kj can be written as
78 kj = n
  1
2
n X
i=1
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T
n
b  kb  k(⌧
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Tb ⌃(⌧
⇤)
 1 
 k k(⌧
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T⌃(⌧
⇤)
 1 
d{y
⇤
iI it⇤
i  i⌧⇤}b z
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⇤
+
n
  1
2
n X
i=1
Z
T
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T⌃(⌧
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 1µ(⌧
⇤) 
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Tb ⌃(⌧
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 1b µ(⌧
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o
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i  i⌧⇤}b z
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ij
i
=
Z
T
Gn1(⌧
⇤)dHn1(⌧
⇤)+
Z
T
Gn2(⌧
⇤)dHn2(⌧
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where Gn1(⌧
⇤)=b  kb  k(⌧
⇤)
Tb ⌃(⌧
⇤)
 1    k k(⌧
⇤)
T⌃(⌧
⇤)
 1,
Hn1(⌧
⇤)=n
  1
2
n X
i=1
y
⇤
ib z
⇤
ijI it⇤
i  i⌧⇤
Gn2(⌧
⇤)= k k(⌧
⇤)
T⌃(⌧
⇤)
 1µ(⌧
⇤)   b  kb  k(⌧
⇤)
Tb ⌃(⌧
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 1b µ(⌧
⇤),
Hn2(⌧
⇤)=n
  1
2
n X
i=1
b z
⇤
ijI it⇤
i  i⌧⇤
and I t⇤ ⌧⇤ = I{ rt⇤
r r⌧⇤
r }1rR.
Assumption A.3 in Web Appendix A ensures that E(b z⇤
ijI it⇤
i  i⌧⇤)=0a n ds t a n d a r de m -
pirical process theory yields the fact that Hn2(⌧ ⇤)c o n v e r g e sw e a k l yt oaz e r o - m e a nG a u s s i a n
process under H0 Pollard (1990). To see that Hn1(⌧ ⇤)s i m i l a r l yc o n v e r g e st oaz e r o - m e a n
Gaussian process, consider
Hn1(⌧
⇤)=n
  1
2
n X
i=1
y
⇤
ib z
⇤
ijI it⇤
i  i⌧⇤
= n
  1
2
n X
i=1
y
⇤
i
h
z
⇤
ij + gj(✓j,xi)   gj(b ✓j,xi)
i
I it⇤
i  i⌧⇤
= n
  1
2
n X
i=1
y
⇤
i
h
z
⇤
ij   ˙ gj(✓j,xi)
T(b ✓j   ✓j)
i
I it⇤
i  i⌧⇤ + op(1)
= n
  1
2
n X
i=1
z
⇤
ij
 
y
⇤
iI it⇤
i  i⌧⇤ 
E
⇥
y
⇤
iI it⇤
i  i⌧⇤ ˙ gj(✓j,xi)
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+ op(1)
Then, under H0,
E
⇥
z
⇤
ij
 
y
⇤
iI it⇤
i  i⌧⇤   E
⇥
y
⇤
iI it⇤
i  i⌧⇤ ˙ gj(✓j,xi)
T⇤
Uj(xi)
 ⇤
=0
79and Hn1(⌧ ⇤)c o n v e r g e st oaz e r o - m e a nG a u s s i a np r o c e s s .
Now Gn1  ! p 0 and Gn2  ! p 0 by consistency of FPCA estimates Hall et al.
(2006). Therefore, by Proposition 7.27 of Kosorok (2008),
R
T Gnr(⌧ ⇤)dHnr0(⌧ ⇤) ! 0
as n !1 ,f o rr =1 ,2. since Gn1,G n2 and G = 0 have bounded total variation,
R
T Hnr(t)dGnr(t)  
R
T Hr(t)dG(t)=0f o rr =1 ,2. Then, integrating by parts,
 kj =
P2
r=1
⇥R
T Gnr(t)dHnr(t)
⇤
=
P2
r=1
⇥
Gnr(t)Hnr(t)|T  
R
T Hnr(t)dGnr(t)
⇤
=
P2
r=1
⇥
 
R
T Hnr(t)dGnr(t)
⇤
+ op(1)  
P2
r=1
⇥
 
R
T H(t)dG(t)
⇤
=0b e c a u s eGnr = op(1)
and Hnr = Op(1). The result qkj   e qkj = op(1) follows.
To obtain the null distribution of Q,c o n s i d e r i n ge q u a t i o n s( 3 . 1 0 )a n d( 3 . 1 1 ) ,o b s e r v e
that Q has the same asymptotic null distribution as
e Q = e q
Te q = u
Tu + op(1)
for u =( ukj)j2S,1kK,a n dukj = n  1
2
Pn
i=1 Qikj = n  1
2
Pn
i=1{e ⇠ik   AkjU(xi)}z⇤
ij.L e t
 =C o v ( u), and deﬁne  1/2 to be the symmetric half matrix such that  1/2 1/2 =  .T h e n
e Q = u
T 
 1/2  
 1/2u + op(1)
= e u
TUAU
Te u + op(1)
where U is an orthonormal matrix of the eigenvectors of  , A is a diagonal matrix of the
eigenvalues of  , and e u =   1/2u is asymptotically standard multivariate normal by the
central limit theorem. Noting that, because U is orthonormal, U
Te u is also asymptotically
standard normal, e u
TUAU
Te u =
PsK
k=1 ak(u⇤
k)2 where u⇤
k is an element of the asymptotically
standard normal U
Te u and ak an eigenvalue of  . It ﬁnally follows that Q ⇠
PsK
l=1 al 2
1.
3.6.3 Justiﬁcation for the form of the test statistic
In this section, we establish the relation between the score with respect to ⌘2,
@ logL⇤(0)/@(⌘2), and the form used to derive the test statistic
E

@ logL(0)
@⌘
| V
 2
+ E

@2 logL(0)
@⌘2 | V
 
.
80First note that
lim
⌘!0
@ logL⇤(⌘)
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=l i m
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1
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@⌘
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1
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because @L⇤(0)/@⌘ = 0. Now consider that
L
⇤(0) = exp
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Thus,
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And the result is established.
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